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SUMMARY 
Type II sodium-phosphate cotransporters (NaPi-II), encoded by the SLC34 gene family, play an 
important physiological role in the homeostasis of inorganic phosphate (Pi). Three protein isoforms 
are found in mammals designated NaPi-IIa, NaPi-IIb and NaPi-IIc (or SLC34A1,2,3). They are 
integral membrane proteins that mediate uphill Pi transport driven by the electrochemical gradient 
of sodium. Their tissue localization determines their physiological role: whereas NaPi-IIa and NaPi-
IIc are mainly expressed in the renal proximal tubule, NaPi-IIb is expressed in the small intestine 
and other non-renal epithelial-like cells. Disturbed phosphate homeostasis is associated with many 
diseases. The ability to modulate the activity of NaPi-II in controlling phosphate absorption could 
have a large clinical impact, particularly in end stage renal disease where the ability to excrete 
phosphate is compromised, leading to high plasma levels and vascular calcification. For this reason 
the investigation of the structure-function relationships of these transport proteins has clinical 
relevance for the development of specifically targeted drugs.  
Three themes are covered in this thesis: 
Characterization of the cotransport dynamics  
Protein conformational changes occurring during the transport cycle can be investigated with 
voltage clamp fluorometry (VCF), whereby a thiol reactive fluorescence molecule is used as an 
indirect reporter of motion. This technique applied to NaPi-IIb containing substituted cysteines has 
revealed complementary movement of two protein domains during the transport cycle. Using VCF 
applied to mutant transporters that retain their basic function after labelling with the fluorophore, a 
more detailed “map” of the movements of different domains of the protein during the transport 
cycle under physiological conditions was obtained. 
Moreover, by combining VCF and presteady-state analysis, we investigated the correlation of 
kinetics of voltage-dependent transitions (manifested as presteady-state relaxations) with the 
kinetics of localized microenvironment changes, reported by changes in fluorescence intensity (ΔF). 
A direct correlation would suggest that the fluorophore senses the interaction of ions and the charge 
movement attributed to the empty carrier. Our findings allow us to relate protein rearrangements 
with the voltage-dependent events during the transport cycle such as substrate binding and 
translocation and predict the location of cation binding sites. 
Identification of an internal cation release step  
Knowledge of the internal release and binding of substrates to NaPi-II is limited. New insight was 
obtained using the electroneutral NaPi-IIc isoform. Electrogenicity of NaPi-IIc was restored by 
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replacing of three conserved amino acids, found in all electrogenic isoforms, at corresponding sites 
in NaPi-IIc. The Na+:Pi stoichiometry of this engineered electrogenic construct (AAD-IIc) increased 
from 2:1 to 3:1. Accompanying this fundamental functional change, AAD-IIc also showed a 
different behaviour from the wild-type electrogenic NaPi-IIa/b, specifically a reduced apparent Pi 
affinity and different presteady-state kinetics. This compromised behaviour was investigated using 
electrophysiology and voltage clamp fluorometry (VCF). The activation energy of AAD-IIc was 
considerably different from NaPi-IIc and NaPi-IIa; in particular AAD-IIc shows a higher activation 
energy associated with the empty carrier reorientation. These studies have shown that the AAD-IIc 
retains the electroneutral cooperative interaction of 2 Na+ ions of the electroneutral NaPi-IIc and the 
presteady-state charge relaxations of AAD-IIc are mainly due to the empty carrier (in the absence of 
external Pi), and to the cytosolic release of one Na+ ion (in the presence of Pi). Using simulations of 
presteady-state and steady-state behavior, it was possible to identify two critical partial reactions: 
the final release of Na+ to the cytosol and external Pi binding. Moreover, using VCF with Cys-
mutants of AAD-IIc we confirmed the predictions from the model simulation.  
Homology model and substrate binding sites localization 
The transport mechanism and structure-function relationships of sodium-dependent phosphate 
cotransporter (NaPi-II) have been extensively studied; however, its 3D structure is still unknown. 
Although the structures of some sodium-dependent cotransporters have been resolved, the classical 
bioinformatic approaches fail to identify a suitable template for the creation of homology model of 
NaPi-II. Using hydrophobicity profiles and hidden Markov Models it was possible to define a 
structural repeat common to all NaPi-II isoforms. Now, using the recently solved crystal structure of 
Vibrio cholerae Na+-dicarboxylate transporter VcINDY as a template, we were able to generate a 
homology model of human NaPi-IIa. The predicted Na+ and Pi coordination sites are localized in 
specific repeat motifs in the center of the protein and furthermore biochemical and 
electrophysiological investigations have confirmed the importance of key amino acids predicted to 
be involved in substrate coordination. 
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ZUSAMMENFASSUNG 
Natriumphosphat-Kotransporter vom Typ II (NaPi-II), kodiert von der SLC34 Genfamilie, 
spielen eine wichtige physiologische Rolle in der Homöostase von anorganischem Phosphat (Pi). 
Bei Säugetieren findet man von ihnen drei Proteinisoformen, genannt NaPi-IIa, NaPi-IIb und NaPi-
IIc (oder SLC34A1,2,3). Diese sind wesentliche Membranproteine, die den Transport von Pi gegen 
den Gradienten erleichtern. Der Transport wird durch den elektrochemischen Gradienten des 
Natriums angetrieben.  
Die Lokalisierung im Gewebe bestimmt ihre physiologische Aufgabe: Während NaPi-IIa and 
NaPi-IIc vorwiegend in der sogenannten „renal proximal tubule“ exprimiert werden, wird NaPi-IIb 
im Dünndarm und anderen nicht renalen Zellen, wie Epithelzellen, in der Genexpression. Eine 
gestörte Phosphathomöostase wird mit vielfältigen Erkrankungen in Verbindung gebracht. Die 
Fähigkeit, die Aktivität von NaPi-II zu beeinflussen, indem die Phosphatabsorption kontrolliert 
wird, könnte großen klinischen Einfluss ausüben, besonders im Bereich von Nierenerkrankungen 
im Endstadium. Bei diesen ist die Fähigkeit zur Phosphatausscheidung beeinträchtigt. Dies 
wiederum führt zu einem hohen Plasmaspiegel und Gefäßverkalkung. Gerade aus diesem Grund hat 
die Erforschung der Beziehung zwischen Struktur und Funktion dieser Transportproteine große 
klinische Relevanz in der Entwicklung von spezialisierten Medikamenten. In der vorliegenden 
Dissertation werden nun drei Themen abgedeckt: 
Charakterisierung der Kotransportdynamik 
Treten während des Transportzyklus Veränderungen in der Proteinkonformation auf, so können 
diese mit Hilfe der sogenannten „voltage clamp fluorometry (VCF)“ untersucht werden. Dabei wird 
ein Molekül, das bei Zugabe von Thiol fluoresziert, als indirekter Nachweis von Bewegung genutzt. 
Die Technik wurde auf NaPi-IIb angewandt, welches substituierte Cysteine enthielt. Enthüllt 
wurden in Folge komplementäre Bewegungen zweier Proteindomänen, die während des 
Transportzyklus vorkamen. Nun wandte man VCF auf mutierte Transporter an, die mit dem 
Fluorophor markiert wurden, ihre grundlegende Funktion jedoch behalten hatten, und erhielt 
eindetaillierteres Bild der Bewegungen von verschiedenen Proteindomänen während des 
Transportzyklus unter physiologischen Bedingungen. 
Durch die Kombination von VCF und der sogenannten „presteady-state analysis“, untersuchten 
wir den Zusammenhang zwischen der Kinetik von spannungsabhängigen Übergängen (welche 
offenbar sogenannte„presteady-state relaxations“ sind) und der Kinetik von lokalisierten 
Veränderungen in der Mikroumgebung. Letztere wurden durch Veränderungen in der 
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Fluoreszenzintensität sichtbar (ΔF). Ein direkter Zusammenhang würde nahelegen, dass das 
Fluorophor die Interaktion von Ionen und die Übergänge durch das unbeladene Carrier-Protein 
erfassen kann. Unsere Entdeckungen erlauben es uns, Neuzusammensetzungen der Proteine mit den 
spannungsabhängigen Vorkommnissen während des Transportzyklus, wie der Substratbindung und 
Translokation, in Verbindung zu bringen und die Orte der Kationbindungen vorherzusagen.  
Identifizierung eines internen Schrittes der Kationabgabe 
Das Wissen um die interne Abgabe und Bindung von Substraten an NaPi-II ist begrenzt. Einen 
neuen Einblick hat jedoch die Nutzung der elektonisch neutralen Isoform von NaPi-IIc ermöglicht. 
Die Elektrogenität von NaPi-IIc wurde wiederhergestellt, indem man drei konservierte 
Aminosäuren an korrespondierenden Orten in NaPi-IIc ersetzt hat, welche man in allen 
elektrogenen Isoformen findet. Die Na+:Pi Stöchiometrie dieses speziell entwickelten elektrogenen 
Konstruktes (AAD-IIc) hat sich von 2:1 auf 3:1 erhöht. Zusätzlich zu dieser fundamentalen 
funktionellen Veränderung, hat AAD-IIc ein vom Wildtyp, dem elektrogenen NaPi-IIa/b, 
verschiedenes Verhalten gezeigt. Im Besonderen sind zu nennen: eine offensichtliche reduzierte Pi 
Affinität und eine veränderte Kinetik, welche dem Festzustand vorausgeht. Dieses beeinträchtigte 
Verhalten wurde durch Elektrophysiologie und „voltage clamp fluorometry (VCF)“ untersucht. Die 
Aktivierungsenergie von AAD-IIc unterschied sich erheblich von der des NaPi-IIc und NaPi-IIa. 
Insbesondere zeigt AAD-IIc in Verbindung mit der Neuorientierung des unbeladenen Carrier-
Proteins eine höhere Aktivierungsenergie. Die vorliegenden Studien haben gezeigt, dass AAD-IIc 
die elektroneutrale, kooperative Interaktion mit 2 Na+ Ionen des elektroneutralen NaPi-IIc aufrecht 
erhält. Außerdem zeigte sich, dass der Nachlass in der elektrischen Ladung des AAD-IIc vor dem 
Festzustand, vor allem wegen des unbeladenen Carriers (in Abwesenheit externen Phosphats und 
der Abgabe von Na+ Ionen (in Anwesenheit von Pi ) auftritt. Durch den Gebrauch von 
Simulationen zum Verhalten im Prägleichgewichtszustand („presteady-state“) und 
Gleichgewichtszustand („steady-state“), war es möglich, zwei kritische partielle Reaktionen zu 
identifizieren: Die finale Abgabe von Na+ ins Cytosol und die externe Pi Bindung. Außerdem, 
durch die Nutzung von VCF mit Cysmutaten von AAD-IIc, konnten die Vorhersagen durch die 
Modellsimulationen bestätigt werden. 
Homologiemodell und die Lokalisierung von Orten der Substratbindung 
Der Transportmechanismus und die Struktur-Funktion-Beziehungen des natriumabhängigen 
Phosphatkotranspoters (NaPi-II) wurden ausführlich untersucht. Trotzdem ist seine 
dreidimensionale Struktur weiterhin weitgehend unbekannt. Obwohl die Strukturen verschiedenster 
natriumabhängiger Kotransporter entdeckt wurden, scheitern klassische Annäherungen der 
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Bioinformatik am Problem, ein passendes Muster für ein Homologiemodell von NaPi-II zu finden. 
Indem Hydrophobieprofile und Markov Modelle genutzt wurden, war es möglich, eine strukturelle 
Wiederholung zu definieren, welche alle NaPi-II gemein haben. Nun, durch die Nutzung der 
kürzlich aufgelösten kristallinen Struktur des Vibrio cholerae Na+-dicarboxylate Transporters, 
VcINDY, als Modell, konnte ein Homologiemuster von humanem NaPi-IIa generiert werden. Die 
vorhergesagten Na+ und Pi Koordinierungsorte wurden in speziellen, sich wiederholenden Motiven, 
im Zentrum des Proteins, lokalisiert. Weiterhin haben elektrophysiologische Untersuchungen die 
Bedeutung von Schlüssel-Aminosäuren enthüllt, welche laut Vorhersage in der 
Substratkoordinierung involviert sein sollen
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ABBREVIATIONS 
AAD-IIc: electrogenic triple mutants of NaPi-IIc (SLC34A3) 
ADP: adenosine diphosphate 
ATP: adenosine triphosphate 
BBMV: brush border membrane vesicle 
BetP: betaine transporter 
cAMP: cyclic adenosine monophosphate 
cGMP:  cyclic guanosine monophosphate 
ClC: family of Cl- transport proteins 
COVC: cut-open Xenopus oocyte voltage clamp  
Ea: activation energy 
EAAT: excitatory amino acid transporter 
EPR: electron paramagnetic resonance 
F: fluorescence emission intensity 
FRET: fluorescence resonance energy transfer 
GAT: GABA transporter 
GltPh: glutamate transporter homolog from (Pyrococcus horikoshii ) 
GLUT: glucose trasporter 
LCP: lipidic cubic phases  
LeuT : bacterial leucine transporter  
MTS: methanethiosulfonate 
MTS-TAMRA: MTS 5(6)-carboxytetramethylrhodamine 
NaDC: Na+ / Dicarboxylate transporters (SLC13) 
NaPi-II: sodium dependent phosphate transporter, type II (SLC34 family) 
nH : Hill coefficient 
NhaA: Na+/H+ antiporter 
NI: not injected oocyte 
PDB: Protein Data Bank 
Pi: inorganic phosphate 
qy : apparent quantum yield  
SCAM: substituted cysteine accessibility method 
SDSL: site-directed spin labeling  
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SERT: serotonin transporter (SLC6A4)  
SGLT1: Na+/glucose cotransporter (SLC5A1) 
smFRET: single molecule fluorescence resonance energy transfer 
TEVC : two electrode voltage clamp 
TM: transmembrane segment 
TMD: transmembrane domains 
TMRM: tetramethylrhodamine maleimide 
VCF: voltage clamp fluorometry 
VcINDY: Vibrio cholerae Na+-dicarboxylate transporter 
WT: wild type 
ΔF: change in fluorescence intensity 
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INTRODUCTION 
Membrane transport proteins 
The lipid bilayer establishes a barrier between the external and internal environments of cells. 
Transport of essential nutrients including small polar organic molecules and inorganic ions across 
the bilayer is mediated by specialized integral membrane proteins, which can be divided in two 
groups on the basis of their functional mechanism: ion channels and carriers.  
Ion channels 
Ion channels comprise one or more subunits capable of forming a highly permeable pathway across 
the membrane that allows the passage of ions down their electrochemical gradient. 
Ion channels are characterized by the presence of a gate and a filter for ionic selectivity. The gate 
opening can be mediated by numerous factors; for example, membrane potential, ligand and 
divalent cation interactions, cGMP/cAMP, ADP/ATP hydrolysis, temperature or mechanical forces. 
The ionic selectivity depends on the size of the filter region and on the location of charged residues 
that define the energy profile within the pore (Hille, 2001). 
The major distinction between ion channels and carriers is related to the transport mechanism and 
the transport rate. Channels transport ions exclusively downhill according to the electrochemical 
gradient for the ion. In contrast, some carriers can transport substrate uphill by coupling to the 
electrochemical gradient of another ion (e.g. the sodium-coupled glucose cotransporter SGLT1), 
whereas others act as facilitated diffusers and cannot concentrate substrate (e.g the GLUT family of 
glucose carriers). Moreover, ion channels are characterized by rapid transport rate and this allows 
their activity to be measured by electrophysiology, either at the macroscopic level (whole cell) or 
single channel level (patch clamp) (Hille, 2001). 
Carriers 
Carriers can transport many different types of small organic molecules and ions. Unlike ion 
channels, which are gated to allow ions to flow according to their electrochemical gradient, the 
carrier must selectively bind and release substrates without significant leakage between the external 
and internal cell environment. The transport mechanism follows a series of ordered conformational 
changes in which the substrate binding site is accessible either from the extracellular (outward 
facing conformations) or intracellular (inward facing conformations) side of the membrane. The 
complex sequence of conformational changes thus imposes a limit on the transport rate. The 
turnover rate for carriers is relatively slow compared to ion channels. Typically, carriers can 
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transport up to 103 molecules per second in contrast to channels that can transport ≥107 ions per 
second (Vinothkumar and Henderson, 2010). The lower transport rate of carriers means that for 
electrogenic transport processes, the currents at the single carrier molecule level are too small to 
resolve with current technology and only macroscopic measurements can be made from a large 
population of carrier proteins.  
Due to the identification of new structures of both carriers and channels, the separation between 
these membrane proteins has become blurred. For example in the family of Cl- transport proteins 
(the ClC family) all the members share a conserved structural architecture, however they show 
different functional behaviors: some members work as gated chloride channels and others as 
secondary-active chloride transporters coupled to proton flux. Moreover, the CLC family is 
characterized by the presence of fast pumps, with characteristic small gates that it can move rapidly, 
and by the presence of exceptionally slow ion channels, in which the ion conduction deforms the 
pathway slowing the ion diffusion (Dutzler, 2006; Gadsby, 2009). 
Carriers can be divided in three groups:  
• Uniporters, able to translocate a single substrate across the membrane along its 
electrochemical gradient (also known as facilitated diffusers). 
• Symporters (cotransporter), able to translocate two or more substrates in the same 
direction. 
• Antiporters, able to translocate two substrates in opposite directions. 
Carriers can also be distinguished on the basis of the energetics of the transport process. For 
primary active transport, the source of energy derives from the hydrolysis of ATP and GTP, light or 
redox energy; for secondary active transport, the energy is provided by the co-substrate 
translocation along its electrochemical gradient that promotes the substrate translocation against its 
electrochemical gradient.  
Alternating access model and structural characterization 
According to the alternating access model originally proposed by Jardetzky (Jardetzky, 1966), a 
carrier protein uploads the substrates from one side of the membrane then it changes its 
conformation and releases the substrates to the other side such that during each transport cycle the 
substrates are never exposed to both sides of the membrane simultaneously. To complete the 
transport cycle, a carrier undergoes a series of conformational rearrangements that can be 
generalized as outward facing conformations in which the binding sites are exposed to the 
extracellular environment and inward facing conformations in which the binding sites are expose to 
the intracellular environment (Figure 1).  
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Figure 1 Alternating access mechanisms for symport. Two solutes bind from the outside to form a ternary complex 
(upper right) with the transporter. A conformational change closes external access and opens a path to the inside (right). 
Following dissociation of the solutes, the empty transporter can undergo a second conformational change to regenerate 
the outside-facing form. Note that interconversion of the transporter with a partially filled binding site is incompatible 
with eﬃcient symport of the two solutes. From Rudnick, 2006. 
 
The 3D structure of membrane transporters can provide information about the general architecture 
of the protein in the membrane and its transport mechanism. The most common technique used for 
the identification of the 3D structures of protein is X-ray crystallography. This technique requires 
high quality diffracting crystals that provide sufficient resolution to allow the identification of 
important feature of the transporter such as binding sites etc. The greatest obstacle to the structural 
resolution of membrane proteins derives from their amphiphilicity (property of having hydrophilic 
and hydrophobic regions), this feature causes a misfolding of these proteins in aqueous media; 
therefore the crystal formation represents the critical step. The first advance came in the 1980’s with 
the use of detergent-based micelles designed to solubilize membrane proteins; this method led to the 
first structure of a membrane protein (Deisenhofer et al., 1985). The second breakthrough came in 
1996 with the new approach of lipidic cubic phases (LCP): Bacteriorhodopsin was the first 
membrane protein crystallized using LCP crystallization (Landau and Rosenbusch, 1996). 
Thanks to these and other technical advances, the number of resolved and known 3D structures of 
transmembrane proteins has markedly increased; however, it is estimated that membrane proteins 
encoded in the human genome number at least 10,000 and up to now only approximately 700 of 
these have been structurally resolved (http://blanco.biomol.uci.edu/Membrane_Proteins_xtal). 
Most of the 3D crystal structures reported for different carrier appear to be perfectly consistent with 
the alternating access model. Figure 2 shows a schematic representation of the conformational 
changes for the bacterial leucine transporter (LeuT) (Krishnamurthy and Gouaux, 2012). 
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Figure 2 Schematic of transport in LeuT. a–c, Shown are structural elements and gating residues instrumental to 
conformational changes associated with the transition from the outward-open (a) to the outward-occluded state (b) and 
the inward-open state (c). At present there is no crystal structure for an inward-occluded state and thus no schematic is 
provided. From Krishnamurthy and Gouaux, 2012. 
Secondary active transporters 
Secondary active transporters are involved in a variety of important cellular functions. They are 
responsible for transmembrane transport of essential metabolites, ion homeostasis and synaptic 
function. Secondary active transporters can be divided into different families based on their primary 
structures (Busch and Saier, 2002), hydropathy profiles (Lolkema and Slotboom, 2003), and driving 
cation (mainly Na+ and H+).  
The classification based on functional and phylogenetic properties identifies about 5000 
representative transporters (Saier et al., 2009). However to detect more distant evolutionary 
relationships between proteins the hydropathy profile analysis is recommended. For example, with 
this method Lolkema included 32 families of transporter proteins in a unique structural class 
designated ST[3], among which are LeuT, vSGLT1, BetP. (Lolkema and Slotboom, 2003).   
Moreover, the recent determination of 3D structures at atomic resolution improved the transporter 
classification on the base of their folding (Forrest et al., 2011). 
One common characteristic of these proteins is the evidence of a gene duplication in their evolution: 
transmembrane segments are duplicated, moreover a duplication of helical bundles can causes a 
parallel or antiparallel orientation (Vinothkumar and Henderson, 2010; Forrest, 2013). Most of 
these transporters have structural architectures characterized by a pseudo-two-fold symmetry. Their 
structures can be divided in two units that have a slightly different arrangements and such 
differences lead to the structural asymmetry. The difference between the units allows the opening of 
a gate while the other is closed thereby satisfying the alternating access requirement (Figure 3B) 
(Forrest, 2013).  
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Figure 3 A) Inverted-topology repeats with similar structures can form channels through the membrane. (B) In 
transporters, the difference between the two halves creates an asymmetry in the overall protein structure, resulting in 
opening of the outer or inner gate. (C) In the antiparallel form of the dimeric transporter EmrE, the outside-open 
structure (left) has the same energy as the inside-open structure (right, same structure rotated 180°). (D) In lactose 
permease, the repeated elements of the protein are part of a continuous polymer chain and are intertwined. As in EmrE, 
the two halves appear to alternate between two distinct conformations. (E) Exchange between the two conformations of 
the aspartate transporter, GltPh, involves a dramatic elevator-like movement of the substrate across the membrane. From 
Forrest, 2013. 
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Sodium coupled transporters 
Sodium coupled transporters are secondary active transporters in which the substrate transport 
energy is derived from the sodium transmembrane gradient. 
The first 3D structure at atomic resolution of a sodium-coupled secondary active transporter was the 
glutamate transporter homolog GltPh (Yernool et al., 2004), followed by the Na+/H+ antiporter 
NhaA (Hunte et al., 2005) and the bacterial leucine transporter LeuT (Yamashita et al., 2005). The 
core region of these transporters has a similar fold despite the difference in preferred substrates and 
the difference in their sequences. Their structure has revealed the inverted topology architecture as a 
structural means by which alternating access can be readily achieved; this common architecture 
defines a central substrate translocation pathway with the substrate binding sites located 
approximately halfway through the membrane. Through relatively simple structural rearrangements, 
we can easily imagine how the access from the external or internal side of the membrane can be 
achieved.  
Unknown conformational states of secondary active transporters can be generated by homology 
modeling and bioinformatic approaches (Forrest et al., 2008; Crisman et al., 2009; Radestock and 
Forrest, 2011). The ability to recognize two homologous repeat units with a slight asymmetry has 
allowed two units to be swapped to obtain a different conformational state. This approach has been 
used for the first time on LeuT transporter (Forrest et al., 2008), subsequently new conformational 
states of the LacY transporter were resolved (Figure 4).  
 
Figure 4 Models of the outward-facing conformation of LacY generated by swapping the conformations of the 
repeats or by using the crystal structure of FucP in an outward-facing conformation as a template. The inward-
facing crystal structure (a and b) is compared to the outward-facing repeat-swapped model (c and d) and to the outward-
facing model based on FucP (e and f). The transporter is viewed along the plane of the membrane (a, c, and e) or from 
the periplasm (b, d, and f). From Radestock and Forrest, 2011. 
 16	  
	  
 
Substrate binding for sodium coupled transporters 
Identification of the substrate binding sites represents one of the important steps toward the 
elucidation of the transport mechanism. For sodium-dependent cotransporters like LeuT and 
vSGLT, the main chain carbonyl oxygen atoms and the negatively charged side chains from Glu or 
Asp are involved in the binding coordination (Perez and Ziegler, 2013). In most cases, this site is 
localized in the discontinuous transmembrane helices. Moreover, one or more aromatic amino acids 
are frequently presented adjacent to the substrate-binding sites and they are involved in the 
formation of the occluded conformation (Figure 2).  
For LeuT, the crystal structure estimates the presence of two sodium binding sites designated Na1 
and Na2; the Na1 site is coordinated by two main-chain carbonyl oxygens (A22, T254) and three 
side-chain oxygens (N27, N286, T254). The Na2 site is instead coordinated by three main-chain 
carbonylic oxygens (G20, V23, A351) and by two side-chain hydroxylic oxygens (T354, S355). It 
has been hypothesized that the Na2 is important for the stabilization of the binding pocket and that 
it may help to facilitate the binging of the Na1 through a positive cooperation (Perez and Ziegler, 
2013).  
vSGLT is able to transport only one Na+ ion per transport cycle; by structural comparison with 
LeuT it was possible to identify the sodium binding site at the level of Na2, which is coordinated by 
two hydroxy side chains (S365, S364) and by two backbone oxygen atoms from residues A361,A62 
and I65 (Perez and Ziegler, 2013) (Figure 5). 
 
 
Figure 5 Sodium binding sites in LeuT and vSGLT. Sodium ions are in yellow. Modified from Perez and Ziegler, 
2013  
 17	  
	  
 
Transport kinetics of sodium coupled transporters 
Before the advent of expression cloning, transport kinetics of specific transport systems were 
studied using native membrane preparations. For epithelial transport systems, the brush border 
membrane vesicle (BBMV) preparation was one of the most commonly used (Biber et al., 2007). 
Bacterial transporters (e.g. lactose permease), which could be purified, were studied using a 
liposome preparation (Garcia et al., 1983). One disadvantage of these techniques is that the 
transport process is assayed under non-real-time conditions (tracer uptake) and in the case of the 
BBMV preparation, several isoforms of transporters might mediate transport of the same substrate. 
Expression cloning has allowed a more detailed characterization of transport kinetics of sodium 
coupled transporters to be performed under conditions in which contamination from endogenous 
membrane proteins can be minimized and well defined driving force conditions. In this respect the 
X. laevis oocyte expression system has become the method of choice, at least for eukaryotic 
proteins. A variety of different assays can be performed using this system such as standard tracer 
influx or efflux assays even applied to single oocytes. In the case of electrogenic transporters, 
electrophysiological measurements on single oocytes can be made using the two electrode voltage 
clamp (TEVC) and patch clamp methods (Wagner et al., 2000; Bossi et al., 2007; Kvist et al., 
2011). The latter technique can also be applied to cultured cells transfected to express the protein of 
interest. The principal advantage of voltage clamping the cell membrane is that it allows the 
membrane potential to be defined and transport kinetics (in terms of the transmembrane current) to 
be studied in real time. 
Electrogenic sodium coupled transporters are generally characterized by two types of currents that 
depend on the voltage clamp protocol: 
1. Steady-state currents: measured as the difference between the current in presence and in 
absence of substrates at a constant membrane potential. The transport currents measured at each 
voltage can be plotted as a function of membrane potential to obtain a current-voltage 
relationship (IV plot). Steady-state protocols can be used to obtain information regarding the 
apparent substrate affinity and the maximum transport rate. 
2. Presteady-state currents: observed in respond to rapid changes in the membrane potential. 
The cell membrane acts as an electrical capacitor and a change in the membrane potential 
induces transient displacement currents as equal and opposite free charges move from the bulk 
extracellular and intracellular media to align with the lipid bilayer: the total charge moved is 
proportional to the change in membrane potential. For an oocyte expressing electrogenic 
carriers, an additional relaxing current component is superimposed on the linear endogenous 
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component. The charge associated with these so-called “presteady-state currents” is a non-linear 
function of the change in membrane potential. The charge movements are related to the 
rearrangement of intrinsic charge or polar amino acids of the protein (i.e. associated with the so-
called empty carrier), and to the movement of charged substrates with the membrane electric 
field, which appears across the protein. To resolve the presteady state currents associated with 
the electrogenic carrier it is necessary to eliminate the oocyte endogenous capacitive charging 
component from the total current; this is done by fitting the transient currents with a multiple 
exponential function. Generally, the linear endogenous component is faster than the transporter 
related components and the endogenous component can be subtracted from the total current 
relaxations.  
For a population of carriers, the macroscopic presteady-state relaxations could arise according 
to a deterministic model with each protein contributing the same microscopic relaxing charge 
movement or a stochastic type model, where the charge displacements are rapid and determined 
by the probability of the movement taking place (Figure 6).  
In analogy to the stochastic mechanism of voltage gating proposed for ion channels (Bezanilla, 
2005), the stochastic model is favoured. Moreover, smFRET measurements (see below) of 
transporter conformational changes also reveal the stochastic nature of the conformation 
changes (Akyuz et al., 2013). 
 
 
 
Figure 6 Schematic representation of deterministic (left) and the stochastic (right) model that could explain the 
macroscopic presteady-state current relaxation. In each case the same current would be measured from a population 
of transporters in response to a voltage step although the underlying microscopic mechanism is different. In the 
deterministic model, each protein can be modeled as a series R-C circuit. From Forster IC, unpublished figure. 
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Presteady state currents have been documented for many electrogenic sodium coupled 
transporters for example the hSGLT1 (Loo et al., 1993) (Figure 7), EAAT2 (Wadiche et al., 
1995), GAT1 (Mager et al., 1993), NaDC-1 (Pajor et al., 1998) NaPi-II (Forster et al., 1998). 
 
 
 
Figure 7 Transient and steady-state current. Records made in the presence of 0-20 mM aMeGlc in the Na buffer 
(100mM Na+). Vh was -50mVand the membrane was stepped to +30 and -130 mV. As the substrate concentration 
increases, the relaxations are suppressed, indicating that in the cotransport mode, there is no net mobile charge 
movement within the transmembrane electrical field. From Loo et al., 1993.  
Transport dynamics for sodium coupled transporters 
 
In general the 3D structures obtained using X-ray crystallography or homology modelling give a 
non-physiological view of the protein because they represent a specific conformation that depends 
on the crystallization conditions. This limitation becomes important when considering that a 
complete description of the transport function requires the identification of all the possible 
conformational states and the probability of transitions between states to occur.  
Indirect evidence of transporter dynamic processes were obtained with different techniques such as 
single-molecule fluorescence resonance energy transfer (smFRET) (Brunger et al., 2011), electron 
paramagnetic resonance (EPR) (Klare, 2013) and voltage clamp fluorometry (VCF). 
Single-molecule fluorescence resonance energy transfer (smFRET) 
The technique of smFRET can be used to visualize several steps in the cycle of a transporter as it 
translocates a substrate. This technique involves measuring the distance between fluorescent probes 
(donor and acceptor dyes) attached at strategic sites of a protein. In particular, the dipole-dipole 
interaction between donor and acceptor causes energy transfer, which leads to an increase in the 
acceptor emission and a decrease in the donor emission (FRET or Förster (Fluorescence) Resonance 
Energy Transfer). The energy transfer efficiency depends on the distance and the orientation 
between the two dyes. In this way it is possible to monitor the time course and magnitude of 
conformational changes, and moreover to determine the time spent in a particular conformation 
(Brunger et al., 2011) (Figure 8). 
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This technique was used to investigate the conformational changes that are associated with substrate 
binding and transport for LeuT transporter (Zhao et al., 2010). It was observed that the movement 
of specific transmembrane segment (TM1) is associated with the intracellular gating. These 
movements can be modulated by the presence of substrates or inhibitors and by mutations that can 
stabilized an inward-closed state (Zhao et al., 2010).  
A disadvantage of the smFRET technique, as applied here, is that it requires purified protein. 
Moreover, smFRET has so far been performed on immobilized on surfaces or stabilized in 
liposomes that may compromise the protein folding and its activity. 
 
Figure 8 smFRET in LeuT.  His-tagged, dye-labelled LeuT-H7C/R86C was immobilized by biotin-NTA-Ni2+ to the 
streptavidin-treated surface. From  Zhao et al., 2010 . 
 
Electron paramagnetic resonance (EPR) 
Site-directed spin labeling (SDSL) in combination with electron paramagnetic resonance (EPR) 
spectroscopy are used to elucidate the structure and the conformational dynamics of carrier under 
conditions close to the physiological state. Cysteine substitution mutagenesis followed by 
modification of the sulfhydryl group with a nitroxide reagent is used for the introduction of spin 
labels (SDSL methods) (Figure 9). EPR spectroscopy of the spin-labeled molecules allows one to 
obtain information about the nitroxide side-chain such as solvent accessibility, mobility and the 
polarity of its immediate environment. Moreover, intramolecular or intermolecular distances 
between two or more nitroxides can be obtain with a resolution of ∼8 to 80 Å (Klare, 2013).  
Claxton and colleagues used site-directed spin labeling and electron paramagnetic resonance 
spectroscopy to analyze the dynamics that are associated with the substrate binding of LeuT in a 
specific extracellular region. They observed that the binding of inhibitors induces peculiar structural 
changes in LeuT, different from the ones induced by the leucine interaction (Claxton et al., 2010). 
EPR has similar disadvantages, as indicated above for smFRET. 
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Figure 9 SDSL methods. A. After site-directed mutagenesis to replace the residue of interest by cysteine, reaction of 
the MTSSL with the sulfhydryl group of the cysteine yields the spin label side chain commonly abbreviated as R1. 
Rotatable bonds are indicated in a stick representation of the R1 side-chain structure. B. Selection of spin label agents 
for the modification cysteine side chains. Image and legend from Klare, 2013. 	  
Voltage clamp fluorometry (VCF) 
Voltage clamp fluorometry (VCF) is a real-time approach that allows the indirect visualisation of 
protein conformational changes under physiological conditions and is particularly applicable to the 
the Xenopus oocyte system, working with single cells.  
In the VCF approach, a cysteine mutant of the protein is expressed in a model system (usually X. 
laevis oocytes) and a thiol-reactive fluorophore is covalently linked to the engineered cysteine; 
native cysteines are assumed to remain unlabeled. It is important to ensure that the mutagenesis and 
the labeling do not alter the transport kinetics. 
Changes in fluorescence intensity are due to modification of the microenvironment around the 
fluorophore caused by the conformational rearrangement of the protein. For the interpretation of the 
data obtained with VCF it is necessary to consider that changes in fluorescence arise from a large 
population of transporters that are assumed to move independently in a stochastic manner (Figure 
10); therefore the fluorescence changes are related to the occupancy probability of the different 
conformational states. The occupancy probability, in case of electrogenic cotransporters, can be 
modulated by voltage and by changes in substrate and cosubstrate concentration in the extracellular 
solution.  
The physical response time of the fluorophore to these changes is approximately 10-8 seconds; this 
means that major protein conformational changes, which are expected to occur in the order of 10-6 
seconds or slower in case of cotransporter, can be recorded in real-time.  
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Figure 10 Cartoon illustrating a basic principle of VCF. A section of oocyte membrane is shown.The fluorescence 
changes are quantal events arising from a large population of transporters that change conformation independently. 
From Forster IC, unpublished figure. 
 
The VCF technique was developed by Isacoff and colleagues with the aim of studying 
conformational rearrangements in the potassium channel (Shaker K+ channel) (Mannuzzu et al., 
1996) by combining electrophysiological and fluorescence measurements simultaneously. Using 
this technique, they were able to confirmed the presence of gating charge in the S4 segment of 
potassium channel and that its activation involves the movement of the amino terminal portion of 
S4 from a position that is buried in the membrane to a more exposed position in the extracellular 
environment (Mannuzzu et al., 1996). 
To date, a number of laboratories have used this technique to investigate the transport dynamics in 
different sodium coupled transporters. The Wright group used voltage-clamp fluorometry applied to 
the human Na+/glucose cotransporter (hSGLT1) to examine the partial reactions involving sugar 
binding and its transport. They were able to establish that the partial reaction involving sugar 
binding and Na+/sugar cotransport were neither voltage-dependent nor rate limiting. Moreover they 
demonstrated that the presence of sugar in the external solution increased the occupancy probability 
of an inward-facing conformation (Loo et al., 2006). 
Other insights regarding the conformation dynamic in the glutamate transporter (EAAT) were made 
by the Larsson group (Larsson, 2004). They demonstrated that EAAT transporter undergoes at least 
three major conformational changes during each transport cycle; moreover the reported results 
suggest that the binding of Na+ causes an additional conformational change that precedes glutamate 
binding. 
The VCF hardware comprises two parts: the electrophysiological and photonic components (Figure 
11). The former comprises standard two-electrode voltage clamp (TEVC) hardware with an oocyte 
recording chamber fitted with a transparent base positioned above a fluorescence objective. The 
photonic components comprises a stable light source and shutter, an optical cube containing 
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dichroic mirror and filters for defining the excitation and emission spectra, and a photodiode 
detector. The photocurrent is then converted to a voltage signal using a low noise integrating patch 
clamp amplifier.  
 
 
Figure 11 Voltage Clamp Fluorometry setup. VCF hardware comprises a conventional TEVC with oocyte mounted 
in a recording chamber with a transparent bottom. A simple fluorescent microscope allows the fluorophore excitation 
and the emitted light is measured using a photodiode connected to an integrating current-to-voltage converter. From 
Forster et al. 2012. 
 
Although this technique has proven to be very useful in the study of protein dynamics, its potential 
limitation arises from the interpretation of the fluorescence changes; different mechanisms have 
been proposed to explain this phenomena (Cha and Bezanilla, 1998). Fluorescence changes can be 
postulated to arise from: 
1. re-orientation of the fluorophore’s transition dipole; 
2. shift in the excitation spectrum of the fluorescent label; 
3. interaction with nearby protein residues that can quench the fluorophore; 
4. changes in the hydrophobicity of the fluorophore’s environment. 
Further insights into the underlying mechanism for the changes in fluorescence were obtained by 
for example fluorescence quencher or analysis of the chemical properties of the fluorophore used. 
To improve the interpretation of the VCF results, the Bezanilla group (Cha and Bezanilla, 1998) 
have investigated if the fluorescence quenching was caused by interaction of the fluorophore with a 
nearby region of protein or to exposition of the fluorophore to the aqueous environment. They 
added iodide (I-) to the external solution; this negatively charged anion can amplify the decrease of 
fluorescence intensity (collisonal quenching) if the fluorophore is located in sites accessible to the 
external medium. Using two mutants of Shaker potassium channel (M356C and A359C) labeled 
with the fluorophore tetramethylrhodamine maleimide (TMRM), they detected an increase in the 
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fluorescence quenching in presence of I- at two different membrane potentiasl. These results 
demonstrate that the accessibility of the fluorophore to the aqueous environment at these particular 
sites is independent of the assumed conformational states and therefore they concluded that the 
effect of nearby protein residues is the major cause of fluorescence quenching. (Cha and Bezanilla, 
1998). Iodide was used also by Isacoff and colleagues to interpret the quenching phenomenon for 
other different mutants of the Shaker potassium channel; in this case, they detect an increase of 
fluorescence quenching caused by the presence of iodide for only one mutant (A359C) (Mannuzzu 
et al., 1996).  
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Na+/Pi cotransporters 
This thesis focuses on the structure-function relationships of the Na+-coupled inorganic phosphate 
cotransporters from the SLC34 family. These proteins play an essential role in phosphate 
homeostasis in mammals and have been extensively studied in both the physiological context as 
well as the molecular level (for reviews: (Forster et al., 2012, 2013) (Biber et al., 2013)). What 
follows is a brief overview of their physiological role, kinetics and structure function features at the 
start of the research period. 
Inorganic phosphate in its physiological context-the need for active transport 
Phosphorus is an essential constituent of all living cells and plays key roles in protein synthesis, 
energy transduction, signaling, and maintaining the integrity of the genetic material. Phosphorus is 
present in every organism, plant and animal on Earth. The average adult human contains about 600 
g of phosphorus present in the form of complex organic compounds in the blood, muscles, and 
nerves, and in the form of calcium phosphate in bones and teeth. Phosphorus that is not complexed 
or bound to protein appears as free phosphate ions in solution called inorganic phosphate (Pi); at the 
physiological pH (7.4) it comprises HPO42- and H2PO4- ions in a 4:1 ratio. All Pi is sourced from the 
daily diet; the recommended intake is 1400 mg/day (Boron and Boulpaep, 2012).  
Given the importance of Pi in many biological processes, its circulating plasma levels are regulated 
such that the plasma phosphate concentration is typically maintained in the range 0.8-1.5 mM. Pi 
homeostasis is controlled at three sites: kidney, small intestine and bones. Thus, serum Pi  can be 
affected by modulation of intestinal absorption, renal re-absorption or excretion and exchange 
between extracellular compartments and bone storage (Penido, Maria Goretti M G and Alon, 2012). 
At the cellular level, the movement of Pi across the luminal membrane requires an active membrane 
transport process due to the anionic nature of the solute and the need for vectorial flux of Pi from 
the lumen to blood. The energy for the process is derived from the electrochemical gradient for 
sodium ions and represents one of the most common strategies utilized by solute transport systems 
(Vinothkumar and Henderson, 2010).  
In mammals, there are two distinct families of sodium-coupled cotransporters that mediate the 
Pi transport: SLC20 and SLC34. The SLC20 family comprises two members SLC20A1 (PiT-1) and 
SLC20A2 (PiT-2), the SLC34 family comprises three members SLC34A1 (NaPi-IIa), SLC34A2 
(NaPi-IIb) and SLC34A3 (NaPi-IIc). All these proteins have a high specificity for transporting 
anionic Pi by using the electrochemical gradient of sodium as a driving force for transport. There 
are two main differences between these families: tissue localization and preferred species of Pi 
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transported. At the RNA level, SLC34 members are highly expressed in two organs, kidney and 
small intestine, whereas the SLC20 members are ubiquitously expressed (Figure 12). At 
physiological pH (7.4) Pi is present as monovalent (H2PO4−) and divalent (HPO42−) ions (4:1); the 
SLC20 family preferentially transport monovalent Pi in contrast to the SLC34 family that prefer 
divalent Pi.  
Tissue localization and physiological relevance of SLC34 proteins 
The members of SLC34 are the principal responsible for the Pi homeostasis. Among the SLC34 
family, the three isoforms NaPi-IIa/b/c show different tissue localization: 1) the isoforms NaPi-IIa/c 
are mainly expressed in the kidney and they are responsible for the re-absorption of Pi in the 
nephrons 2) the isoform NaPi-IIb is mainly express in the small intestine and it is responsible for 
the absorption of Pi from the diet (Figure 12). Moreover, NaPi-IIc may also have a role in the bone 
mineralization (Segawa et al., 2009) as discussed below. 
NaPi-IIa/b cotransporters are characterized by a Na+: Pi stoichiometry of 3:1, in contrast to NaPi-IIc 
that shows a 2:1 stoichiometry. This difference results in a 100-fold increase in the Pi concentrating 
capacity of NaPi-IIa/b. The physiological consequences of this difference have not been fully 
elucidated.  
 
 
 
 
 
 
Figure 12 Tissue localization of mRNA Na/Pi-II cotransporters. the mRNAs of NaPi-IIa and II-c are mainly present 
in the kidney whereas expression of NaPi-IIb is mainly found in lung and small intestine and non-renal epithelia. 
Modified from  Forster et al., 2013 . 
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Intestinal phosphate absorption 
 Dietary phosphate is absorbed mainly in the epithelium of the small intestine through the cellular 
and the paracellular pathways; the NaPi-IIb isoform is responsible for the cellular pathway uptake, 
and it is highly expressed at the luminal surface of the enterocyte (Eto et al., 2006). Inward Pi flux 
via NaPi-IIb results from the electrochemical gradient of the sodium maintained by the Na+/K+-
ATPase pump at the basolateral membrane (Figure 13).  
 
 
 
 
Figure 13 Phosphate transport in the intestine. NaPi-IIb is expressed at the luminal surface of the enterocyte, the 
electrochemical gradient of the sodium is maintained by the Na+/K+-ATPase pump. The basolateral pathway for Pi 
efflux from the cytosol is not yet identified 
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Renal phosphate reabsorption 
The kidney is the main organ responsible for the Pi homeostasis. Under physiological conditions 80-
90% of the filtered phosphorus is reabsorbed; the remainder is excreted in the urine. The 
reabsorption of phosphate occurs primarily in the proximal tubule: Pi enters the cell through the 
apical membrane by the NaPi-IIa/c and exits at the basolateral membrane by an unknown 
transporter. Unlike intestinal absorption, in the kidney there is no evidence of paracellular transport 
pathway (Ullrich and Murer, 1982). The Na+/K+-ATPase pump is required to maintain the sodium 
electrochemical gradient to drive transport the active transport (Figure 14).  
 
 
Figure 14 Localization of phosphate transport proteins in the kidney. The Pi reabsorption pathway through 
proximal tubule epithelia shows that NaPi-IIa and NaPi-IIc transport divalent Pi (HPO42−), whereas PiT-2 prefers 
monovalent Pi (H2PO4−), The basolateral exit pathway remains unknown. NaPi-lla, NaPi-llc and Pit-2 are localized at 
the brush borders membranes of epithelial in S1 and S2 segments of the proximal tubule cells, whereas NaPi-llc is 
absent in S3 segments. Modified from  Biber et al., 2013. 
Phosphate importance for the bone health  
Phosphate and calcium are the basic components of the inorganic constituent of the bones 
(hydroxyapatite); it follows that maintaining physiological phosphate balance has a crucial 
biological importance for bone health. Osteoporosis is a common form of bone disease, and it is 
characterized by the deterioration of the bone structure and by low bone mass. Studies for the 
osteoporosis prevention have always been focused primarily on calcium, however, these studies are 
now concentrated on the importance of the balance of calcium and phosphorus in treatment for this 
diseases (Kuntz et al., 1986). 
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Dysfunction of phosphate transporters  
Given the great importance of the phosphate for many biological processes, it follows that 
hypophosphatemia or hyperphosphatemia, which result from compromised regulation of transporter 
expression or specific mutations that affect targeting and function, can have adverse clinical 
consequences (Figure 5). Some diseases can be directly related to malfunctioning of specific NaPi-
II isoform. In most cases, the mutations appear to affect the population of transporters expressed in 
the membrane rather than the transport function itself. 
NaPi-IIa 
Heterozygous alterations in the gene that encodes for the NaPi-IIa transporter are reported to cause 
urolithiasis and bone demineralization (Prié et al., 2002), moreover a heterozygous duplication in 
the same gene causes Fanconi renotubular syndrome 2 (Magen et al., 2010). This syndrome is 
characterized by severe renal phosphate wasting, renal failure and hypophosphatemic rickets with 
grave bone deformities, fractures, and stunted growth. 
NaPi-IIb 
The loss of function of NaPi-IIb transporter in the intestine can be compensated by an increase of 
the NaPi-IIa expression in renal proximal tubule to reduce the Pi excretion, which is the reason why 
the heterozygous alteration in its encoding gene is often silent. Nevertheless, pulmonary alveolar 
microlothiasis can manifest itself in case of autosomal recessive inheritance. NaPi-IIb is, in fact, 
expressed in the lungs and it is responsible for the transport the Pi from the alveolar space into the 
alveolar cells; alteration in its function makes the cells unable to remove phosphorus from the 
alveolar space causing accumulation (Kashyap and Mohapatra, 2013). 
NaPi-IIc 
Mutations in NaPi-IIc protein are associated with hereditary hypophosphatemic rickets with 
hypercalciuria, a rare autosomal recessive disorder (Bergwitz et al., 2006). 
In humans, mutations in the gene encoding the type IIc sodium–dependent phosphate transporter 
lead to hereditary hypophophatemic rickets with hypercalciuria. Mice homozygous mutants (NaPi-
IIc−/−) exhibit hypercalcemia, hypercalciuria and elevated plasma vitamin D, but they do not 
develop hypophosphatemia, hyperphosphaturia, renal calcification, rickets, or osteomalacia. The 
Miyamoto group has suggested that NaPi-IIc is responsible for the maintaining of a normal calcium 
metabolism, in part achieved by modulating the vitamin D level (Segawa et al., 2009). 
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Figure 15 Diseases associated with dysregulation/dysfunction of phosphate transporters. Proposed but not 
identified disease associations are indicated by a question mark (?). Modified from  Lederer and Miyamoto, 2012 . 
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Transport kinetics  
Transport kinetics of the electrogenic isoforms of NaPi-II 
The initial investigations on Pi transporter were done in brush-border membrane vesicles isolated 
from small intestine (Berner et al., 1976) and kidney (Hoffmann et al., 1976), in which it was 
reported that Pi transport dependended on external Na+ ions and was therefore most likely secondary 
active process. These early studies were unable to clearly identify if the transport process was 
electrogenic or not. The first identification of a NaPi-II isoforms was reported in 1993 by 
expression cloning using cDNA libraries derived from rat and human kidney and by the functional 
expression of in X. laevis oocytes. (Magagnin et al., 1993).  
Subsequent studies on the kinetic characterization of the different isoforms of NaPi-II were mostly 
done by heterologous expression in X. laevis oocytes, using two electrode voltage clamp (TEVC) 
and radioactive trace uptake ((Busch et al., 1994), for review see (Forster et al., 2012; Biber et al., 
2013) 
The Na:Pi transport stoichiometry of 3:1 for two electrogenic isoforms of NaPi-II was determined 
in 1999 (Forster et al., 1999). This was achieved by simultaneous measurements of phosphate 
induced inward current and uptake of radioactive 32Pi and 22Na in X. laevis oocytes. Figure 16A 
shows a representative electrophysiological recording of phosphate induced current for an oocyte 
expressing the flounder NaPi-IIb isoform and voltage clamped to -50 mV at pH 7.4. Figure 16B 
shows the relationships between the net charge transferred, obtained by integration of the Pi-
induced current with time, and the corresponding Pi and Na+ uptake. The slope of the line fitted to 
the Q/Pi  data is close to unity, thus one net positive charge was transferred per Pi transported; the 
slope of the line fitted to the Q/Na data was close to 0.3, these findings were consistent with three 
Na+ ions being transported per net inward charge. 
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Figure 16 Cotransport stoichiometry. A. Representative electrophysiological recording of phosphate–induced 
current. Example recording from a control (non-injected) oocyte (upper trace) and an oocyte expressing the flounder 
isoform NaPi-IIb (lower trace). B. Relationship between the net charge transfer (Q) and Na or Pi uptake for oocytes 
expressing the flounder NaPi-IIb isoforms at holding potential of -50 mV and pH of  7.4. Each point represents data 
from a single oocyte. Modified from  Forster et al., 1999.  
 
It is now known that NaPi-II proteins possess different stoichiometries: NaPi-IIa and NaPi-IIb are 
electrogenic with three Na+ ions and one HPO42- cotransported inside the cell for a total net 
translocation of one positive charge and NaPi-IIc is electroneutral  with a stoichiometry of two Na+ 
ions and one HPO42- (see below). 
Binding order 
Coransport of Pi by NaPi-II proceeds in an ordered manner and different kinetic studies established 
the binding order of substrate and cosubstrate. On the basis of electrophysiological assays, a kinetic 
model was proposed in 1998 (Figure 17). Each numeral represents a unique conformational state of 
the protein and the arrows indicate partial reactions that reflect molecular rearrangements as 
substrates bind and debind. This model proposed that the interaction of one sodium ion occurred 
before Pi binding, and at least one sodium ion was the last substrate to bind (Forster et al., 1998).  
 
Figure 17A kinetic scheme of an ordered binding model for NaPi-II. Each number represents a unique 
conformational state of the protein and the double arrows represent allowed partial reactions between the states. From 
Forster et al., 1998. 
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This model was revised with the studies performed with the voltage clamp fluorometry (VCF) 
technique (Virkki et al., 2006b) in which it was proposed that two sodium ions bind sequentially the 
protein before Pi binds.  
Figure 18 shows the current kinetic model proposed for the electrogenic isoform of NaPi-II. 
Transitions 0-1 and 5-6 are related to the translocation between the outward facing conformation 
and inward facing conformation; the partial reactions between states 0 and 2 are involved in charge 
translocation. The partial reactions that occur in the extracellular environment have been well 
investigated in oocytes because the external superfusion solutions could be easily changed; in 
contrast the conformational changes and the order of substrate release that occur in the cytosol were 
still unknown. 
 
 
 
Figure 18 Kinetic scheme for electrogenic cotransport cycle. Transitions 0-1 and 5-6 represent the translocation 
between the outward face conformation and inward facing conformations. States 1-5 represent externally orientated 
conformations environment and states 0, 6-9 represent internally orientated conformations. A leak pathway operates (2-
9) in the absence of external (Andrini et al., 2008). 
 
The Pi apparent affinity (K0.5Pi) for the three NaPi-II isoforms was estimated with the TEVC, by 
measuring the Pi–induced current in NaPi-II expressing oocytes as a function of membrane potential 
(IV plot), for different Pi concentration in the extracellular solution (Figure 19). The transposed 
data were then fitted with Michaelis-Menten equation allowing the estimation of the Pi apparent 
affinity as ∼0.1 mM (pH 7.4 and [Na+] =96 mM). The apparent affinity for Na (K0.5Na) is in the 
range 40-60 mM (determined with 1 mM Pi) and is comparable among the different isoforms. These 
apparent affinities indicate that in mammals, under physiological conditions, the NaPi-II isoforms 
can function close to their maximum transport velocity. 
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Figure 19 IV data for NaPi-IIa depicting phosphate-dependent current as a function of membrane potential A. 
Representative data for one oocyte superfused with 96 mM external Na+ and different Pi concentrations in the range 
0.006–1.0 mM from which the apparent Pi affinity was determined. B. Representative data for one oocyte with 1mM Pi 
and Na+ different concentrations from which the apparent Na+ affinity was determined. From  Forster et al., 1998 . 
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Steady state and presteady state current 
Figure 20 shows representative TEVC current recordings data from a X. laevis oocyte expressing 
flounder NaPi-IIb isoform for different steps of voltage and for two external solutions (100 mM Na+ 
and 100 mM Na+ + 1 mM Pi). From these data it is possible to distinguish the two types of currents: 
presteady-state currents that relax within the first 20 ms after the voltage steps and the steady state 
currents (page 17). Presteady-state current relaxations depend on the external Na+ concentration and 
they are suppressed in presence of Pi but still visible in absence in Na+.  .	  
 
 
Figure 20 Representative current recorded form X. laevis oocyte expressing flounder NaPi-IIb. Left: currents 
recorded in presence of 100 mM Na+ (100Na) , right: currents recorded in presence of 100Na + 1mMPi. 
 
The time constant of the exogenous relaxation and the number of charges that are involved in the 
cotransport cycle (Figure 21) can then be quantified. Analysis of the NaPi-II presteady-state 
relaxations can be summarized in terms of two graphical representations: the time constant (τ) and 
charge (Q) plotted as a function of membrane voltage, respectively. 
The τ-V plot of the Figure 21A shows a strong dependence of the time constant of presteady-state 
currents on membrane voltage. This voltage dependence arises from transitions between 
conformational states that involve charges sensing the membrane potential: at very positive 
potentials, most of the transporters occupy state 0 (Figure 18), while at very negative potentials, 
state 3 (Figure 18) is occupied with the higher probability.  
The Q-V (Figure 21B) data can be fitted with a single Boltzmann function:  
 
                 Q(V)= Qmax/1+exp (V0.5-V)ze/kT)+Qhyp                   (Eq. 1 from (Forster et al., 2012) 
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where: 
Q(V) is the charge displaced for a voltage step from a given holding potential to V;  
z is the slope factor indicating the apparent valence for an equivalent charged entity that moves in 
the membrane electric field; 
Qmax  is the total charge displaced; 
Qhyp  is the charge at the hyperpolarizing  extreme; 
V0.5  is the voltage at 50% of the total charge has been displaced;  
k, e, T have their usual meaning. 
The Boltzmann model applied here assumes the system can be reduced to two states with a lumped 
effective charge that is displaced across a fraction of the transmembrane electric field. Although this 
can seem like a significant over-simplification, it helps to interpret the observed behavior in terms 
of a simple charge displacement system. 
The parameters V0.5 and z can be used to compare the voltage-dependent behavior under different 
superfusion conditions and between isoforms as well as mutants. 
 
 
 
 
Figure 21 Time constant and charge movements obtained from analysis of presteady-state current under 
different superfusion conditions. A. voltage dependence of the main relaxation time constant (τ) as a function of the 
different Na+ concentrations. B. Corresponding voltage dependence of the on-charge (Qon) associated with the main 
relaxation component plotted for different Na+ concentrations. Continuous lines are fits with eq. 1. From  Forster et al., 
2012. 
Transport kinetics of NaPi-IIc  
The isoform NaPi-IIc was cloned in 2002 by the Miyamoto group (Segawa et al., 2002). NaPi-IIc is 
the unique isoform of the NaPi-II family for it is electroneutral, with a Na:Pi stochiometry of 2:1 
(Bacconi et al., 2005). Moreover, Xenopus oocytes expressing functional NaPi-IIc do not show 
presteady-state relaxations, this can be explained by the absence of voltage-dependent partial 
reactions that contribute to its transport cycle. The absence of presteady-state currents represent, 
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also, a first hint of a different sodium binding phenomenon compared with the electrogenic 
isoforms. Uptake, efflux and voltage clamp fluorometry experiments have allowed elucidation of 
this difference (Ghezzi et al., 2009). Three sodium ions can interact with the electroneutral isoform 
NaPi-IIc but, in contrast to the electrogenic isoforms, only two sodium ions can be translocated 
inside the cell; the first sodium act as catalyst for the subsequent partial reactions (Figure 22 ). The 
apparent substrate affinities for NaPi-IIc are similar to NaPi-IIa/b and this suggests that all three 
isoforms share the same common substrate recognition elements.  
At the primary structure level, the main difference between the electrogenic and electroneutral 
isoform appears to be the presence of a negative charged amino acid (aspartic acid) that in the 
electrogenic isoform would favor the first sodium interaction and promote the outward open 
conformation after the release of all substrate in the cytosol (Figure 22). Amino acid sequence 
analysis between the three different NaPi-II isoforms reveal an high degree of similarity, in support 
of the similar transport kinetics among isoforms. The study conducted by our laboratory (Bacconi et 
al., 2005) reported that the electrogenicity of NaPi-IIc could be restored by replacing of three 
conserved amino acids, found in all electrogenic isoforms, at corresponding sites in NaPi-IIc 
(S189A, S191A, and G195D). The Na+:Pi stoichiometry of this engineered electrogenic construct 
(AAD-IIc) increased from 2:1 to 3:1 and the presteady-state current were detected. Accompanying 
this fundamental functional change, AAD-IIc also showed a different behaviour from the wild-type 
electrogenic NaPi-IIa/b, specifically a reduced apparent Pi affinity and different presteady-state 
kinetics (Bacconi et al., 2005).  
 
Figure 22 Cartoon of substrate interaction with the electrogenic isoform NaPi-IIa and the electroneutral 
isoform NaPi-IIc. For the electrogenic NaPi-IIa, an intrinsic negative charge (proposed to be an aspartic acid) confers 
voltage dependence to the transport cycle. This allows the binding of the first Na+ ion and his subsequent translocation 
together with the other substrates, giving a 3:1 Na+: Pi stoichiometry (left and upper part). All substrates are released 
to the cytosol, the intrinsic charge senses the transmembrane field, leading to a voltage-dependent reorientation of the 
empty carrier (upper right). Electroneutral NaPi-IIc, which contains a conserved glycine at the same site, binds one 
Na+ ion, like NaPi-IIa, but this ion is not translocated, giving the 2:1 Na+: Pi transport stoichiometry. Modified from 
Biber et al., 2013. 
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Structure and binding sites 
Unfortunately, the crystallized structure of homologs of NaPi-II is not yet available; however, it is 
reasonable to think that it should have similar structure to the other sodium-dependent transporters. 
Without experimental structure data available, we must rely on homology modeling to obtain a 3D 
view of NaPi-II; this is a multi-step process in which the first step is represented by the research of 
modeling template obtained usually performing a BLAST or PSI-BLAST search against the Protein 
Data Bank (PDB). Before 2012, an adequate template for NaPi-II was unavailable. Despite this 
limitation, investigating the structural properties of NaPi-II has remained an active field and 
different techniques have been used for that purpose. For example, the combination of molecular 
biology and electrophysiological assays was used to identify amino acids with structural and 
functional relevance. Moreover, a topological model of NaPi-II was solved by combining 
combination of bioinformatics methods and functional validation. Diﬀerent algorithms predict 8–12 
transmembrane domains (TMDs) and experimental evidence confirmed the intracellular orientation 
of both N- and C-termini and the presence of a large hydrophilic extracellular loop between the 5-6 
TMDs (Radanovic et al., 2006) (Figure 23), in this loop a disulfide bridge was found that helps to 
stabilize the structure (Lambert et al., 2000). 
 
 
 
Figure 23 Topology model based on rat NaPi-IIa sequence. The model was drawn using TOPO2 
software(http://www.sacs.ucsf.edu/TOPO/topo.html). Enlarged symbols indicate sites of significant structure–function 
importance. Pink: Identical residues in the re-entrant repeats; green: sites when mutated to a Cys that are externally 
accessible; blue: sites when mutated to a cysteine that are internally accessible; purple: sites externally inaccessible; 
red: sites critical for electrogenicity; orange: sites important for regulation and targeting; black: native Cys; grey: 
determinants of pH dependence. An essential disulfide bridge in the large extracellular loop is indicated (dashed line). 
From Forster et al.,2012. 
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The topological model was experimentally confirmed mainly using biochemical and biophysical 
studies. Epitope labeling revealed intracellular location for the NH2- and COOH-termini (Lambert 
et al., 1999). The substituted cysteine accessibility method (SCAM) was used to estimate degree of 
accessibility for extracellular linkers (Lambert et al., 2001; Ehnes et al., 2004b), to identify 
functional important sites (Köhler et al., 2002a, 2003; Ehnes et al., 2004a) and to predict an α-
helical organization for the transmembrane segment 9 (Lambert et al., 2001). 
SCAM is used for mapping the intracellular and extracellular accessible sites and can also give 
information about the importance of specific sites for the protein function. The basic SCAM 
protocol requires mutating, one by one, different amino acid residues to a cysteine, then the protein 
is expressed in a model system and the substituted cysteine is labeled with methanethiosulfonate 
(MTS) functionalized compounds. The cysteine modification often causes an alteration of the 
functionality of the protein such as an impairment of transport activity; exposing the cotransporter 
to a fixed and moderate concentration of MTS reagent for different periods allows the loss of 
activity to be followed that reflects the number of modified proteins. By plotting the transport 
current against the cumulative time of exposure to the MTS reagent and fitting the line with a single 
decay exponential function it is possible to obtained the rate of cysteine modification (Karlin and 
Akabas, 1998). This procedure assumes that the reaction can be reduced to a 1st order system. By 
comparing the modification rates for different substitution sites, their relative accessibility to the 
medium can be derived. 
There are two possible ways to test the function alteration of the proteins: the radioactive transport 
assay and the real time electrophysiological measurement. To compare the apparent reaction rate of 
different mutants, it is important to fix the conditions of the assay to define the state occupancy of 
the protein. Radioactive tracer transport assays as used, for example, in SCAM studies of the 
serotonin transporter (SERT) (Chen et al., 1997)) and the glutamate transporter (EAAT) (Leighton 
et al., 2002) have the disadvantage of not allowing straightforward control of the voltage membrane 
and this could lead to errors in the reaction rate estimation. In contrast, for electrogenic transporters, 
the reaction can be followed in real time and with controlled membrane potential. All the SCAM 
investigations carried on NaPi-IIa/b have used the real-time electrophysiological measurement. 
Further studies using Cu-phenanthroline to induce a disulfide bridge formation have revealed two 
other important regions in the topology of NaPi-II comprising two reentrant repeats that share a 
sequence identity of more that 30%; these domains are localized between TMDs 3-4 and TMDs 8-9, 
they contain critical sites for the determination of voltage dependence and substrate interaction. The 
results of these studies support the hypothesis of a structural similarity between all members of the 
NaPi-II family (Ghezzi et al., 2011). 
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Without a crystal structure or a homology model for NaPi-II, it is difficult to localize precisely the 
binding site of sodium and phosphate. Based on information obtained from the same family of 
sodium-dependent cotransporters it is possible hypothesize the location of binding sites in the 
discontinuous helices. Moreover, analysis of mutagenesis has allowed validation of the importance 
of certain amino acids for substrate coordination and the transport function, for example, site S448 
in NaPi-IIb (Virkki et al., 2006b) and the corresponding sites in NaPi-IIa (S460) (Lambert 1999) 
and NaPi-IIc (S437) (Ghezzi 2009). 
Transport dynamics 
The first study analyzing the transport dynamics of NaPi-II proteins involved the investigation of 
the fluorescence changes (∆F) for the fNaPi-IIb mutant, S448C (Virkki et al., 2006b). This site was 
chosen based on previous cysteine mutagenesis studies on the rat NaPi-IIa isoform in which site 
Ser-460 was identified as being functionally important (Lambert et al., 1999). After fluorophore 
labeling, S448C showed a suppression of Pi-induced current, indicating an incomplete transport 
cycle and confirmed the previously documented phenotype  (Lambert et al., 1999). However, 
oocytes expressing S448C gave steady-state fluorescence emissions that were dependent on 
membrane potential and substrate (Na+ and Pi). These data indicated that substrates could still 
interact with the protein despite its inability to cotransport Pi. Moreover, the dependence of 
fluorescence quenching could be fitted with the Hill equation: for changes in Na+ concentration a 
Hill coefficient (nH) of 1.8 and for changes in Pi concentration nH was close to unity. These data 
were interpreted as a further indication of the ability of this mutant to interact with 2 Na+ and 1 Pi, 
and as an indication of the ability of the fluorophore’s microenvironment to sense substrate 
interactions. 
As previously discussed (page 17), the presteady-state charge movements provide an indirect 
measure of the global voltage-dependent conformational changes of the protein, in contrast, ∆F 
reports local conformational changes of the protein. To investigate if the kinetics of charge 
movements were reflected in the time course of the fluorescence signal a comparison was done for 
the S448C mutant by plotting parametrically one time constant against the other. A direct 
correlation was found between these two parameters only over a limited potential range (V> −40 
mV) and in the presence of external Na+ ions (Figure 24). These data suggest that the fluorophore 
can detect large transitions occurring between that inward-facing conformation (state 0, Figure 18) 
and the conformations relative to the binding of sodium (state 2 or 3, Figure 18) (Virkki et al., 
2006b). A more detailed interpretation of the relative level of fluorescence intensity in different 
conformational states can be obtained using simulated fluorescence with a kinetic model (see 
Discussion). 
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Figure 24 Presteady-state charge movements and fluorescence. (A) Simultaneous recordings of percent change in 
fluorescence (ΔF/F) for a representative oocyte in response to the voltage step protocol as shown, for superfusion in full 
Na+ (ND100), choline replacement (ND0), and Li+ replacement (LD100) and corresponding presteady-state currents 
(Ipss, black traces). For Ipss, the records were fit with a double decaying exponential and the main component (I2,assumed 
to be S448C-related is shown superimposed, red traces). For the ΔF/F records, the data were fit with a single growing 
exponential, shown superimposed on each trace (red traces). Recording bandwidth was 500 Hz for Ipss and ΔF/F. 
Baseline adjustment was performed for Ipss. (B) Parametric plot of ΔF/F against I2 as a function of time for the cell in A 
at the indicated test potentials. Dotted lines indicate deviations from linear behavior for hyperpolarizing potentials. (C) 
Voltage dependency of the time constants associated with the decay of I2 (ND100) and time-dependent phase of ΔF/F 
(ND100, LD100). Note that the ordinate scale covers two ranges. Data pooled from n = 5 cells. From Virkki et al., 
2006b. 
 
Subsequently, the VCF technique was applied on NaPi-IIb mutants expressed in X. laevis oocytes to 
create a map of the conformational changes that occur in different regions of the protein during the 
transport cycle. The fluorescence changes of four sites (Ser-155, Ser226, Gln-319, Glu-451) of 
NaPi-IIb were investigated under different conditions. Fluorescence was recorded in presence of 
different substrates in the extracellular solution and for different membrane voltages. For mutants 
S155C and S226C, membrane depolarization causes an increase in the fluorescence intensity 
whereas for mutants Q319C and E415C it causes a decrease ( 
Figure 25). These results permitted characterization of the substrate and voltage-dependent 
conformational changes associated with specific partial reactions, a complementary ∆F obtained for 
the different sites suggested that two parts of the protein experience complementary and opposite 
rearrangements for the same change in membrane voltage (Virkki et al., 2006a). 
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Figure 25 Complementary fluorescence changes observed in two parts of NaPi-II. Topological scheme of flNaPi-
IIb isoform shows the localization of the cysteines for mutants S155C, S226C, Q319 and E451C. The original F-V 
recordings made for the corresponding mutant in presence of 100 mM Na+ in the extracellular solution in response to 
the change in the membrane potential. From  Virkki et al., 2006a. 
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OPEN QUESTIONS 
At the start of my dissertation, a number of aspects of the structure-function relationships of NaPi-II 
were still unresolved and three of them were addressed during the dissertation period:  
1) Investigation of the internal substrate release steps.  
2) Construction of a homology model of NaPi-II 
3) Characterization of the cotransport dynamics  
Investigation of the internal substrate release steps  
From the numerous experiments conducted using X. laevis oocytes expressing NaPi-II, it was 
possible to characterize the extracellular conformational states that allow the binding with the 
substrate and co-substrates. For all NaPi-II isoforms, it was established that two sodium ions bind 
before the Pi interaction, followed by a third sodium ion before translocation. However, knowledge 
about the release of the substrates and co-substrate in the intracellular environment is limited. An 
obvious approach would be to modulate the intracellular concentrations of substrate and co-
substrate in the oocytes and to study their influence in the transport kinetic. This approach cannot be 
investigated with the standard two electrode voltage clamp that does not allow ready exchange of 
cytosolic contents. Possible methods that could be applied include the cut-open oocyte voltage 
clamp technique and whole cell patch clamp. 
Construction of an homology model of NaPi-II 
The lack of a resolved crystal structure of NaPi-II or its bacterial homologs has prevented defining 
the location of the sodium and phosphate binding sites or even to identify specific protein 
conformations. Furthermore, the low sequence and structural identity between NaPi-II and the other 
sodium-dependent cotransporters with resolved 3D structures has prevented pursuing homology 
modeling strategies with reasonable confidence.  
In addition, to furthering our general knowledge of the transport mechanism, having a 3D structure 
could help in the design of specific inhibitors with large clinical potential in cases of compromised 
Pi handling such as end stage renal disease. 
Characterization of the cotransport dynamics  
The 3D structures obtained from crystallisation and homology modelling strategies provide a static 
image of one conformational state, and quite likely give a limited, non-physiological view of the 
protein when considering the conditions necessary to obtain diffracting crystals. NaPi-II is a 
cotransporter and its function is tightly connected to the conformational states that it must undergo 
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for the transport to occur. The elucidation of its transport dynamics-how the molecule behaves 
under physiological conditions during the transport cycle- is then crucial to understand the transport 
mechanism at the molecular level. 
METHODS AND RESULTS 
Methods 
Methods used: 
• Single point mutagenesis 
• Two electrode voltage clamp (TEVC) 
• Radiotracer uptake 
• Voltage clamp fluorometry (VCF) 
• Substituted cysteine accessibility method (SCAM) 
PUBLICATIONS THAT CONTRIBUTE TO THIS WORK 
A. Conferring electrogenicity to the electroneutral phosphate cotransporter NaPi-IIc (SLC34A3) 
reveals an internal cation release step. (published (Patti et al., 2013)) 
 
B. Structural model of the human Na+-phosphate cotransporter NaPi-II. (under review) 
 
C. Correlating charge movements with local conformational changes of a Na+-coupled 
cotransporter (ready for submission) 
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A. Conferring electrogenicity to the electroneutral phosphate cotransporter Napi-IIc (SLC34A3) 
reveals an internal cation release step. 
This section contains the original research article published in the European Journal of Physiology 
(Pflügers Archiv) (Patti et al., 2013) 
The aim of this project was to investigate partial reactions that confer the unique properties of 
mutant of NaPi-IIc (AAD-IIc). By studying the kinetics of an electrogenic mutant AAD-IIc we 
were able to identify the internal sodium release step during the transport cycle of NaPi-II. This was 
an unexpected finding and has led to greater insight into the cotransport cycle of NaPi-II proteins. 
My contributions to this paper included performing of part of experiments involving the AAD-IIc 
mutants including voltage clamp fluorometry assay and performing uptake experiments using 32Pi 
in Xenopus oocytes expressing the WT NaPi-IIc isoform at different temperature. I also performed 
data analysis, data interpretation and drafted the manuscript. 
 
 
 
Figure 26 Secondary topology model of AAD-IIc showing the mutants investigated in this paper(black). Red triangles 
indicate the three critical sites for restoring electrogenicity to form the AAD-IIc construct.  
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B. Structural model of the human Na+-phosphate cotransporter NaPi-II. 
This section contains an original research article as submitted to PNAS. It is currently under 
revision.  
This work is the result of a collaboration between the University of Zurich, the Computational 
Biology Group at the MPI-Biophysics, Frankfurt (Head, L R Forrest), Dr A. Werner, Newcastle 
University.  
Our attempts to find a suitable template for the construction of a structural homology model for 
NaPi-II started in 2011 with my visit in the laboratory of Dr Forrest, however at that time no 
suitable template was found. As a result of further work in Frankfurt, a model was developed based 
on the bacterial dicarboxylate cotransporter, VcINDY. 
My contribution to this paper included the design of mutants, molecular biology, transport assays 
on mutants to validate the predicted binding sites. I also participated in the data analysis, data 
interpretation and in the drafting of the manuscript including figures. 
 
 
 
Figure 27 Secondary topology model of hNaPi-IIa showing the mutants investigated in this paper( filled circles).  
 66	  
	  
 
 
 
 
 
 67	  
	  
 
 
 
 
 68	  
	  
 
 
 
 
 69	  
	  
 
 
 
 
 70	  
	  
 
 
 
 
 71	  
	  
 
 
 
 
 
 72	  
	  
 
 
 
 73	  
	  
 
 
 
 
 
 
 74	  
	  
Suplementary information 
 
 75	  
	  
 
 
 
 
 76	  
	  
 
 
 77	  
	  
 
 
 78	  
	  
C. Correlating charge movements with local conformational changes of a Na+-coupled cotransporter 
This section contains a manuscript ready for submission.  
The general aim of this study was to gain insight in the transport dynamics of NaPi-IIb by making 
simultaneous presteady-state charge measurements and fluorescence intensity measurements from 
the same oocyte. It extends a previous fluorometry mapping (Virkki et al., 2006a) study and 
introduces a method to allow the fluorescence properties of different mutants to be compared by 
assigning an apparent quantum yield according to the conformational state occupied.   
My contribution to this paper included study design, mutagenesis, experiments (electrophysiology, 
fluorometry), data analysis and interpretation and writing the first draft of the manuscript including 
preparation of figures. 
 
 
 
Figure 28 Secondary topology model of fNaPi-IIb showing the mutants investigated in this paper. New mutation sites 
are highlighted in red, sites previously investigate by Virkki et al., 2006 (Virkki et al., 2006a) are highlighted in black. 
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DISCUSSION  
Investigation of internal substrate release steps 
Sequence comparison of the electrogenic isoforms NaPi-IIa/b with the electroneutral isoform NaPi-
IIc identified specific amino acids that were critical for the electrogenic behavior (Bacconi et al., 
2005). Electrogenicity was conferred to NaPi-IIc by substitution of three conserved amino acids, 
found in all electrogenic isoforms at corresponding sites in NaPi-IIc and the increase in Na+:Pi 
stoichiometry from 2:1 to 3:1 was confirmed. Nevertheless, this construct (AAD-IIc), showed 
significantly altered transport kinetics compared with the WT electrogenic isoforms. Specifically 
AAD-IIc had a reduced apparent Pi affinity and voltage steps evoked presteady-state currents that 
were not suppressed by external Pi unlike WT NaPi-IIa/b. Moreover, there was little change in 
charge transferred with or without external Na+ ions (Bacconi et al., 2005). The unique behavior of 
AAD-IIc construct could be understood in terms of alterations to specific partial reactions in the 
transport cycle. For a multi-state system, all the rate constants contribute to the overall 
phenomenological transport parameters (apparent affinity, transport velocity) and therefore it is 
difficult to readily identify whether the mutagenesis had affected one or more partial reactions. We 
were able to overcome this difficulty and identify these transitions thanks to three experimental 
strategies conducted using in the TEVC applied to X. laevis oocytes. In these experiments we 
restricted the number of possible states the transporter could occupy and thereby limited the number 
of possible partial reactions that had to be considered: 
 
1. Activation energy (Ea) measurement of AAD-IIc and of WT NaPi-IIa/b in presence 
and absence of co-substrates. 
The rationale for these experiments was that the candidate partial reactions might be 
identified if their activation energy was different from the WT. In these experiments, the 
temperature dependence of the steady-state and presteady-state kinetics was determined and 
two main findings emerged. First, by determining the activation energies for cotransport 
mediated by AAD-IIC, NaPi-IIa and NaPi-IIc, we found that for the electrogenic constructs, 
Ea was significantly larger than for the electroneutral NaPi-IIc. This is indeed what might be 
expected as an electrogenic transport cycle would most likely involve more conformational 
changes (empty carrier charge reorientation and Na+ ion interaction within the 
transmembrane electric field). The Ea for AAD-IIc was double that of NaPi-IIa. This 
established that the mutagenesis had in some way imposed a greater energy cost on the 
AAD-IIc transport cycle. Second, we found that for AAD-IIc, the temperature dependence 
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of cotransport was very similar to that obtained for the relaxation time constant for the 
presteady-state assays in the absence of external Na+. Therefore we initially assumed that 
the mutagenesis had most likely altered the kinetics of the empty carrier. (Figure 30, steps 
1-9). This partial reaction represents a potential rate determining step in the transport cycle. 
 
2. Analysis of the presteady-state current of the AAD-IIc for different superfusion 
conditions. 
We then focused our attention on the kinetics of the presteady-state relaxations as these 
allow specific partial reactions and the associated rate constants to be quantified. Two 
important observations were made. First, analysis of the presteady-state relaxations showed 
that unlike the WT NaPi-IIa or NaPi-IIb, there was little change in total charge movement 
whether external Na+ was present or not. For the electrogenic WT transporters, addition of 
external Na+ causes an approximate 60% increase in total mobile charge (Bacconi et al., 
2005; Forster et al., 2012; Patti et al., 2013). For AAD-IIc this indicated that external Na+ 
ions do not interact with the transmembrane electric field and this was consistent with the 
fact that NaPi-IIc alone does not show presteady-state relaxations. Second, when we applied 
external Pi together with Na+, the charge distribution changed dramatically, but it was not 
suppressed, as we would expect for the WT transporters. Instead the equilibrium potential of 
the voltage dependence of charge vs. voltage data was shifted. This finding meant that in the 
cotransport mode, instead of the protein simply shuttling between the fully loaded carrier 
states (5 and 6, Figure 30), which we assume is an electroneutral transition (Ehnes et al., 
2004a), there was an additional slower electrogenic transition in the cotransport cycle.  
To relate this behavior to our kinetic model, we performed simulations using Berkeley 
Madonna software (http://www.berkeleymadonna.com/). We began with the standard model 
(Ghezzi et al., 2011, 2011, 2011; Andrini et al., 2012, 2012; Meinild and Forster, 2012) and 
assigned most of the mobile charge to the empty carrier and internal Na+ binding. To ensure 
that the kinetic model of AAD-II would be consistent with the real data, it was necessary to 
assign a weak interaction of the first sodium (Figure 30, steps 1-2, 0.1 e- instead of 0.4 e- in 
the corresponding electrogenic partial reaction for NaPi-IIa/b). By increasing the effective 
valence of the partial reaction for the last intracellular sodium binding/release step (Figure 
30, transition 1-9) and setting the release (backward) rate slower than in the standard model, 
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we could successfully recapitulate the presteady-state relaxations in the presence of external 
Pi.  
 
3. Analysis of fluorescence changes (ΔF) in labeled AAD-IIc Cys mutant.  
We expected that the difference in kinetics between AAD-IIc and NaPi-IIa/b should also be 
reflected in differences in conformational changes at the equivalent site or sites in the 
protein. Although we were limited by the number of sites that have been identified so far 
that report conformational changes during the transport cycle, we nevertheless investigated 
the effect of labeling cysteines substituted at 3 equivalent sites previously investigated in 
NaPi-IIb and NaPi-IIc (Virkki et al., 2006b, 2006a; Ghezzi et al., 2009). Only mutant AAD-
IIc-437 showed a different ΔF after fluorophore labeling compared with the corresponding 
mutant in NaPi-IIb (S448C). The difference in ΔF was more evident in the absence of 
external sodium, whereby the AAD-IIc-437 shows a strong quenching of fluorescence 
intensity at positive membrane voltages. Previously it was shown that for the equivalent 
mutant (S448C) in the flounder, quenching of fluorescence occurs for membrane 
hyperpolarization (Figure 29) (Virkki et al., 2006a). For S448C we can interpret the 
quenching with hyperpolarization to result from the protein moving more to outward facing 
states with Na+ bound that have low quantum yields, whereas for depolarizing potentials, the 
protein would be inward facing and give the highest quantum yield. For S437C, it appeared 
that the opposite was the case: states giving the highest quantum yield are outward facing. If 
we assume that quenching results from exposure of the fluorophore to a polar (e.g. 
aqueous/ionic) environment, we might propose that for depolarizing potentials, the 
fluorophore will be exposed to the cytosol and consequently quenched. For hyperpolarizing 
potentials, there is little fluorescence quenching which indicates that the fluorophore’s 
microenvironment is hydrophobic. This is consistent with the lack of external Na+ ion 
movement (presteady-state charge) observed. In summary, site 437 (or 448) allows us to 
view the reorientation of the empty carrier depending on membrane potential. This would 
also accord with an alternating access transport mechanism that allows access to binding 
sites either on the outside or inside, but not both simultaneously. The AAD-IIc retains the 
electroneutral external Na+ interactions as for NaPi-IIc, and the mutations created an 
electrogenic Na+ interaction from the cytosolic side. 
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Figure 29 Na+ dependence of the voltage-dependent fluorescence (ΔF) for mutant S448C in NaPi-IIb and the 
mutant S437C in AAD-IIc. Steady-state fluorescence at different membrane potentials was acquired for each Na+ 
concentration indicated on the figure. Data points are joined for visualization only. Image related to NaPi-IIb-448 from 
Virkki et al., 2006b. 
 
Although the above findings could explain the altered presteady-state kinetics, they were still 
unable to account for the reduced apparent affinity for Pi. Here, we returned to the modeling 
approach and found that by altering the rate constants associated with partial reaction 3-5. We could 
obtain an apparent Pi affinity that agreed with the experimental findings. Thus, we proposed that the 
mutagenesis had (i) imposed a rate limiting step-the release of one Na+ ion to the cytosol and (ii) 
reduced the apparent affinity of Pi by changing the dissociation constant of the Pi binding reaction. 
Figure 30 shows the new kinetic model for the AAD-IIc construct. The pink arrows indicate the 
two partial reactions that are altered compared to the WT electrogenic isoform; the step 0-9 relates 
to the intracellular sodium release and the steps 3-5 relate to the Pi and final Na+ binding. 
 
Figure 30 Kinetic model for the AAD-IIc. Boxed values indicate the effective valence associated with the relative 
partial reaction. Pink arrows emphasize the partial reactions that are compromise in this mutant. Modified from Patti et 
al., 2013. 
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The validity of our kinetic model for the AAD-IIc and our assumption on the rate limiting Na+ 
release step is supported by the behavior of another sodium-dependent cotransporter (SGLT1). 
Wright and colleagues have pointed out the importance of the sodium release step in the 
Na+/glucose cotransporter (SGLT), in which the rate limiting step, at extreme negative potentials is 
equal to the internal sodium ions dissociation rate constant (Parent et al., 1992; Wright et al., 2011). 
All our experiments were performed using the intact oocyte preparation. To investigate further the 
AAD-IIc kinetics, we would need controlled access to the cytosol, for example using the cut-open 
oocyte voltage clamp technique or whole cell patch clamp. Furthermore, it was noted in the original 
work by Bacconi (Bacconi et al., 2005) that three regions were identified as being potentially 
important for conferring electrogenicity. One these regions (Figure 31) originally termed cluster II 
most likely also contains residues that are critical for defining both the substrate affinities and 
overall electrogenic properties and should be addressed in future studies. This region has been 
identified in our homology model to include important residues for sodium and Pi coordination 
(Q417 S418, S419) (see Figure 4D in paper A).  
 
 
 
 
Figure 31 Sequence comparison of NaPi-IIa/c. Multiple sequence alignment indicates position of residues that are 
100% identical in all 21 candidate sequences (Ident), changed between putative electrogenic and electroneutral 
sequences with 100% identity at the respective site (Δ-Ident) or changed with conservative substitutions in either or 
both groups (Δ-Cons). Shaded areas (I, II, and III) indicate clusters of changed residues. Residue numbering is 
according to mouse NaPi-IIa sequence. Topological designation shows position and relative lengths of TMDs and linker 
stretches as predicted by hydrophobicity analysis. NT, N-terminal; CT, C-terminal. From Bacconi et al., 2005. 
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Development of a homology model of NaPi-II 
The rationale for the development of a homology model for NaPi-II proteins was twofold. First, 
further advancement of structure-function studies is severely hampered without a 3-D structure. 
This would lead to a more specific choice of mutagenesis sites and areas of the protein to 
investigate. Second, the synthesis of inhibitors acting with high specificity on NaPi-II proteins 
would have a significant impact in the treatment of diseases related to disorders of Pi homeostasis 
and for this purpose having a 3D structure could accelerate drug design (Gu and Bourne, 2009).  
Although the structures of a number of sodium-dependent cotransporters have been resolved e.g. 
(Yamashita et al., 2005; Faham et al., 2008; Ressl et al., 2009)), the standard bioinformatic 
approaches had failed to identify a suitable template for the creation of homology model of NaPi-II. 
Using hydrophobicity profiles and hidden Markov Models (Yoon, 2009) it was possible to define a 
structural repeat common to all NaPi-II isoforms. Then, using the recently solved crystal structure 
of Vibrio cholerae Na+-dicarboxylate transporter VcINDY (Mancusso et al., 2012), we were able to 
generate a homology model of human NaPi-IIa. Structural information from previous studies has 
allowed us to validate the homology model. For example, using the substituted cysteine 
accessibility method (SCAM (Karlin and Akabas, 1998)) in Xenopus oocytes expressing NaPi-II, 
two regions were identified as accessible to the external medium (Lambert et al., 2001; Ehnes et al., 
2004b); these regions are also externally accessibly in the homology model proposed, 
corresponding to the linker between TM1 and TM2 and to the loop L5ab between TM5a and TM5 
(Figure 32, orange regions). Moreover further studies using SCAM indicated that TM3 region is 
inaccessible from the external medium like in our model (Virkki et al., 2005), we now hypothesize 
that this region acts as a buried “scaffold” of the entire structure (Figure 32, blue regions). 
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Figure 32 Structural model of human NaPi-IIa. A. Location of the structural first repeat unit (green) and second 
repeat unit (pink). Residues accessible to the extracellular side (orange) or buried (blue). B. Close-up of the predicted 
substrate binding sites in NaPi-IIa. 
 
Previous sequence comparisons (Werner and Kinne, 2001) and biochemistry-based studies 
(Lambert et al., 1999) underscored the importance of the QSSS motif found in the N- and C-
terminal halves of the protein and which is conserved down to bacterial isoforms. Two structure-
function studies have focused on potential interactions between the reentrant loops during the 
transport cycle (Köhler et al., 2002b; Ghezzi et al., 2011). These reentrant loops overlap with the 
hairpin loops highlighted in the homology model, in which at the corresponding regions in VcINDY 
the binding sites for Na+ and citrate are localized. We therefore propose the localization of the Na+ 
and Pi interaction sites in NaPi-II based on the symmetry and pseudo-symmetry with VcINDY.  
It was particularly important to obtain functional data to support the proposed model. To this end 
we mutated the candidate sites in the hairpin loops; their expression in the oocyte membrane was 
determined by immunohistochemistry and their functionality was investigated by tracer uptake and 
electrophysiology (steady-state and presteady-state). Nine mutants of the human NaPi-IIa isoform, 
were tested by uptake assay with 32P for sodium-dependent transport. Transport was confirmed for 
two mutants (R210C and Q417C) and was statistically indistinguishable from the non-injected cells 
for S164A/C, T195C, S196C, S418C, S419A/C. This finding alone allowed us to conclude that the 
sites of mutagenesis were in a region critical for transport function. By performing presteady-state 
assays, we were further able to confirm that for 4 sites modified in the first repeat and two sites 
modified in the second repeat, Na+ interactions could still take place. A complete kinetic analysis of 
the mutants was not feasible because of the low functional expression for most constructs. 
Nevertheless for two mutants (R210C and Q417C) we could perform a limited steady-state kinetic 
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analysis to show that for the former, the apparent substrate activation was indistinguishable from 
the WT, whereas for the latter mutant the apparent substrate affinities were reduced (see Table in 
manuscript B). This result confirmed that the residue at site 417 was critical for substrate 
coordination. 
The proposed 3-D model does not make any prediction about the location of the first Na+ ion: for 
the electrogenic isoforms this would possibly interact with charged or polar residues and be located 
deep in the protein to account for presteady-state charge movements. The other two Na+ ions 
together with divalent Pi would thus form an electroneutral complex in the middle of the protein. It 
is this complex that would be translocated for both electroneutral and electrogenic isoforms. 
In conclusion, we have generated a homology model for NaPi-IIa in which we hypothesize the 
location of the substrate biding sites. Validation of this model will require further mutagenesis 
studies and these might best be performed using the well established flounder NaPi-IIb isoform that 
gives greater functional expression even after mutagenesis compared with the mammalian isoforms. 
In particular, the proposed  key amino acids, should be replaced with residues with difference size 
and charge and the kinetic properties of the mutants investigated, similar to a previous study that 
focused on site N199 (Köhler et al., 2002a). 
Characterization of the cotransport dynamics  
Here we focussed on how different parts of the NaPi-II protein respond to changes in membrane 
potential and changes in the external substrate. We used presteady-state charge relaxations and 
fluorophore labelled mutants. An important experimental criterion was that the necessary cysteine 
substitution and subsequent labelling with the fluorophore did not significantly alter the transport 
kinetics. If this criterion is satisfied, we could assume that the fluorescence is an indirect measure of 
local molecular rearrangements of the protein as it moves between states in the transport cycle as 
for the WT. In practice, cysteine substitution at one site did not satisfy our criterion (mutant S144C) 
because labelling caused a significant loss of transport activity (see Supporting Figure 1 in paper 
B). Nevertheless, this result indicated that this site was most likely in a functionally critical 
position.  
To simplify the data interpretation, we focussed mainly on the behaviour of the protein without 
external Pi. For data interpretation we referred to a 5-state kinetic scheme Figure 33A that can 
account for the expected states previously identified from kinetic studies on presteady-state 
relaxations (Ghezzi et al., 2011, 2011, 2011; Andrini et al., 2012, 2012; Meinild and Forster, 2012). 
Based on this model we can solve the differential equations that describe the probability of 
occupancy for each state using modelling software (Berkeley Madonna, 
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(http://www.berkeleymadonna.com/, e.g. (Ghezzi et al., 2011, 2011, 2011; Andrini et al., 2012, 
2012; Meinild and Forster, 2012)). 
Figure 33B shows the probability of the transporter to be in one of these states as a function of 
membrane potential for the case of zero and 100 mM Na+ (external). At extreme positive voltages 
in absence of external Na+ (0Na) the majority of the transporters will assume an inward-open 
conformation, whereas at extreme negative voltages they will assume an outward-open 
conformation (Figure 33B upper panel); this is partly due to a negative intrinsic charge that senses 
the change in voltage and promote specific protein transitions. For superfusion with 100 mM Na+ 
(100Na) at extreme negative voltages the majority of the transporters will assume an outward-open 
conformation in which two Na+ ions are bound (state 3) (Figure 33B lower panel). 
 
Figure 33 Five state kinetic scheme and probability of occupancy of the states. A. Five state kinetic scheme used 
simulate presteady-state and fluorescence behavior. Boxed values indicate apparent valence of the corresponding partial 
reaction. The voltage dependence of these partial reactions was modelled by applying Eyring Transition State Theory to 
describe analytically the dependence of transition rate constants on membrane potential. Voltage-dependent partial 
reactions account for the movement of equivalent lumped charges that change conformational state by crossing a sharp, 
symmetrical energy barrier. B. Number and color of the states are relative to the transitions show in panel A. The state 
occupancy was obtained from simulations of the 5 state model using the following parameters: The rate constants (in s-
1) were as follows: k10=300exp(-Vz10μ/2), k01=100exp(Vz10/2); k12=[Na+]o2000exp(-Vz12 μ/2), k21=500exp(Vz12 μ/2), 
k23=[Na+]o8300, k32=100, k27=1, k07=[Na+]i2000exp(Vz07 μ), k70=500exp(-Vz07 μ) and μ=e/kT≈40	  V-1 at 20 oC, z10=0.4, 
z12=0.4, z07=0.2. The rates constant k72 was defined independently in terms of the other rate constants under conditions 
of zero driving force to satisfy the detailed balance for the leak cycle. We assumed [Na+]i =0.02 M. 
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In the first part of this study, we focussed on the steady-state fluorescence and how this varied with 
membrane potential and whether or not Na+ was present. We also combined data from a previous 
study (Virkki et al., 2006b, 2006a). To better understand the relationship between changes in 
fluorescence intensity and the conformational movements for all the mutants, we have assigned to 
each conformational state a value of fluorescence (F) that depends on the probability of occupancy 
of state (identical value for each mutant) and on the apparent quantum yield associated with the 
different states (these will be different for each mutant); 
 F= ∑ Xn qyn,  
where: 
 Xn is the probability of occupancy of state n 
 qyn is an apparent quantum yield associated with that state 
We then used the 5-state kinetic model and assigned an apparent quantum yield value (qy) to each 
conformational state. We also assumed that the voltage-dependent kinetics were the same for all 
mutants. The effective quantum yield values were determined by trial and error to obtain the best 
visual match between the experimental data and the simulated fluorescence signal. We then 
tabulated the quantum yields by expressing them as a value that defines the fraction of fluorescence 
intensity for each conformational state and for each mutant (Table 1) 
 
 
 
 
 
 
 
 
 
With these data, we can now easily identify the conformational states that are reported by the 
fluorophore at the different labeling sites and how its environment changes from polar (low 
fractional apparent quantum yield) to non-polar (high fractional apparent quantum yield). By 
integrating these data with the location of the mutation sites in the 3-D homology model of NaPi-II, 
it is possible to gain new insights on the conformational changes that occur during the transport 
cycle. For example, the fluorophore placed in position 104 is located in short α-helical segment 
 State 
Mutant 5 4 1 2 3 
A104C 0.49 0.02 0.18 0.09 0.22 
A116C 0 0 0.33 0.33 0.33 
S155C 0.4 0.4 0.2 0 0 
S226C 0.77 0.23 0 0 0 
Q319C 0 0.16 0.32 0.26 0.26 
E451C 0 0.07 0.13 0.27 0.53 
Table 1: Comparison of fractional apparent quantum yields for mutants. Each entry was calculated from the ratio 
of apparent quantum yield for that state divided by the sum of the quantum yields for the particular construct. The 
apparent quantum yield was determined by trial and error to yield a best visual match between the experimental data 
and simulations using the kinetic scheme. The same kinetic parameter was assumed for each mutant 
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separate from the main core region and emits fluorescence when the protein is in anyone of the 5 
conformational states, but with different fractional quantum yields (see Table 1). We hypothesized 
that it senses all the state changes occurring in the adjacent core region. The core region movements 
would cause the fluorophore to be exposed to less polar environments at each potential extreme 
causing the high quantum yields for both inward and outward orientated states.  
In the second part of this study, we combined VCF and presteady-state analysis to investigate the 
correlation of kinetics of voltage-dependent transitions (manifested as presteady-state relaxations) 
with the kinetics of localized microenvironment changes, reported by changes in fluorescence 
intensity (ΔF). Both measurements were made simultaneously on the same oocyte and same 
recording bandwidth. Our working hypothesis was that if there was a direct correlation between the 
two signals, then the conformational changes reported by the fluorescence and the movement of 
charges must arise from the same underlying mechanism.  
Only the mutant S155C showed this correlation in absence and in presence of sodium and over a 
wide potential range, which suggested that the conformational changes reported by the fluorophore 
at Cys-155 reflect those accompanying the charge movement associated with both the empty carrier 
itself and cation interactions. Mutant A116C showed this correlation only in presence of sodium, 
this result was consistent with the detection of finite quantum yield in states 1,2 and 3 (Table 1). 
These findings allow us to relate protein rearrangements with the voltage-dependent events during 
the transport cycle such as substrate binding and translocation and help us to define the protein 
regions with the major functional relevance. 
Two points should be noted in relation to this study. First, we assume that the mutants have exactly 
the same kinetic behavior as the WT. Despite their similarity in phosphate affinity, in fact small 
differences were observed in voltage dependence and in the time constants of presteady state 
current relaxations (mutant S226C in Fig. 4B in paper C). These differences were not included in 
the kinetic model to determine the apparent quantum yields and therefore further refinement of the 
model would be required. 
Second, we assume that the decreased fluorescence emission arises from simple collisional 
quenching. Collisional quenching occurs when the excited fluorophore make contact with an atom 
or molecule that can facilitate the transitions to the ground state in a non-radiative manner. For 
example, water itself can act as collisional quencher (Lakowicz, op. 2006). In accord with this 
assumption, a reduced fluorescence emission may indicated exposure of fluorophore to a more 
aqueous environment. 
However, other mechanisms have been proposed to cause the quenching phenomenon such as: 
i. changes in the rotational freedom of the fluorophore (anisotropy), 
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ii. interactions with a nearby region of protein , 
iii. shifts in the absorption spectrum mainly due to the interaction of nearby fluorophores, 
iii. changes of polarity of the environment (Levshin and Nizamov, 1966; Mannuzzu et al., 1996). 
All these possibilities were investigated in detail for a rhodamine fluorophore (TMRM) used to 
label a heterologously expressed potassium channel (Cha and Bezanilla, 1998).  
We also decide to investigate further the chemical properties of our fluorophore (MTS-TAMRA) to 
improve our interpretation of the fluorescence changes. We focussed on two factors that could 
potentially affect the fluorophore characteristics: i. effect of polar medium; ii. effect of iodide in 
external solution. 
To investigate if the quenching phenomenon for MTS-TAMRA was correlated with the polarity of 
the medium, we tested the emission spectrum in solvents with different polarity (Figure 34). No 
direct correlation between polarity and fluorescence intensity was observed. 
 
Figure 34 Emission spectrum of MTS-TAMRA in presence of solvents with different polarity. Dielectric constants 
for DMSO:46.7,EtOH:24,5, MeOH:33, H2O: 80, CHCl3:4.81. Measurement obtained with the spectrometer Edinburgh 
instruments FLS920 with an excitation light in the range of 538-550 nm. The concentration of MTS-TAMRA was 
0.05mM  for all the solvent tested.  (M. Patti, unpublished data) 
 
To investigate if quenching for labeled oocytes expressing different mutants of NaPi-IIb was caused 
by the exposure of the fluorophore to more aqueous environment, we added I- (iodide) to the 
external solution; this ion is known to be a strong quencher that should amplify the decrease of 
fluorescence intensity (Cha and Bezanilla, 1998). Initially, we investigate the steady state 
fluorescence intensity in presence and in absence of I- for labeled, not injected (NI) oocytes and for 
labeled oocytes expressing different NaPi-II mutants (Figure 35). The resulting data showed a 
stronger quenching phenomenon in presence of I-, nevertheless there was no difference among the 
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data relative to the NI oocytes and the injected ones. The variation of fluorescence for repeated 
measurements most likely results from incomplete washing of excess fluorophore, prevented 
resolution of the fluorescence changes exclusively due to fluorophores covalently bound to the 
transporters. In all subsequent experiments, we focused on the change in fluorescence in response to 
different voltage steps and considered only the changes relative to the different conformations of 
NaPi-II (see Figure 5 in the paper C). 
 
 
Figure 35 Steady state fluorescence changes in presence and in absence of I-. The concentration of Na+ and I- are 
express in mM. These data establish that I- also quenches the background fluorescence (NI oocyte). (M. Patti, 
unpublished data) 
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FUTURE PERSPECTIVES 
Investigation of the internal substrate release steps 
Based on the AAD-IIc study (paper A) we identified a cation release step in the transport cycle of 
NaPi-II. However, our knowledge of the substrate release order and the transition rates of the 
inward face conformations of NaPi-II is still limited. The effect of internal substrates on the 
transport kinetics has been investigated in several studies on other cotransporters. For example, for 
the human serotonin transporter (hSERT), changes in the internal concentration of substrate 
affected the presteady-state and steady-state currents using the cut-open oocyte technique (Adams 
and DeFelice, 2003) and for SGLT1, two studies using patch clamp of oocytes (Sauer et al., 2000; 
Eskandari et al., 2005) estimated apparent affinities for internal substrate interactions. In contrast, 
for the GABA transporter (GAT1) changes in the internal concentration of sodium and chloride in 
intact oocytes were found not to cause any significant changes in the presteady-state currents 
(Cherubino et al., 2012). Further investigations on NaPi-II transport kinetics would profit from 
using cut-open Xenopus oocyte voltage clamp (COVC) technique (Stefani and Bezanilla, 1998). 
With this system it is possible to have simultaneous access to the internal and external faces of the 
transporter to allow investigation of the interactions between substrates in the internal and in the 
external medium.  
Refining the NaPi-II homology model 
Since the homology model of hNaPi-II represents only the outward facing conformation, much of 
the data on the transport dynamics of NaPi-II, obtained by voltage clamp fluorometry (Virkki et al., 
2006b, 2006a; Ghezzi et al., 2011) cannot be completely integrated into this static structural model. 
A homology model of the inward facing conformation will be necessary to hypothesize the 
movements of α-helices during transport and to have a complete understanding of the cotransport 
dynamics. Based on the strategy adopted for LeuT (Forrest and Rudnick, 2009), it may be possible 
to predict an inward facing conformation for our NaPi-II model. This achievement would have 
further impact on the generation of NaPi-II inhibitors using structure-based drug design (Greer et 
al., 1994). 
Single molecule FRET (Zhao et al., 2011; Akyuz et al., 2013) could be used to further validate the 
homology model of NaPi-II in different conformational rearrangements. Using the approaches 
cited, a purified protein would be required, however it might be possible to perform experiments 
using the self-quenching properties of rhodamine applied to the oocyte expression system. Two 
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rhodamine fluorophores such as MTS-TAMRA can stack to form dimeric complex if constrained 
close together or at high concentration. The dimer shows a decrease of the fluorescence intensity 
and it is characterized by a bathochromic shift in the emission spectrum compared with the 
monomer (Figure 36) (Chambers et al., 1974). This so called self-quenching phenomena occur 
when the two molecules are in a short distant of ~1nm (Okoh et al., 2006; Zhou et al., 2011). Using 
this unique feature of rhodamine fluorophore it might be possible to detect intramolecular 
conformational changes in transporters. 
 
Figure 36 Emission spectrum of rhodamine in a monomeric and dimeric complex. From Chambers and Kajiwara, 
1974. 
 
Thus, two rhodamine molecules covalently attached to cysteine in a double cysteine NaPi-II mutant 
can act as “fluorescent rulers” to detect the distance between the two residues.  
Moreover the distance between two cysteine residues could change during the transport cycle as a 
result of conformational rearrangement due to for example of substrate interaction or voltage 
membrane changes (Cha and Bezanilla, 1998). These methods will give new insights in the 
structure of NaPi-II at a higher resolution that can be integrated with the homology model. 
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SUPPLEMENTARY PROJECTS 
During the dissertation period, the author was also directly involved in the experimental design, 
data acquisition and analysis associated with projects that resulted in the following publications and 
therefore appears as co-author. 
1. Development of an ISFET sensor system for non-invasive transport assays on Xenopus oocytes 
(Schaffhauser et al., 2012). 
2. Investigation of the effects of naturally occurring mutations in PiT-2 (SLC20A2) related to basal 
ganglia calcification (Wang et al., 2012). 
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